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1. Introduction 
Despite more than a century of efforts to control malaria, the disease remains a major 
global problem, one of the most severe in public health worldwide. Data from 2006 
suggest that about 3.3 billion people - half of the world's population – are living in 
areas at risk of malaria, an estimated 250 million cases, leading to nearly a million 
deaths (WHO, 2008a), (Figure 1.1). Malaria is a serious problem in Africa, where one 
in every five (20%) childhood deaths is due to the effects of the disease, and every 30 
seconds a child dies from malaria (WHO, 2008a).  
 
Human malaria is caused by infection with intracellular parasites of the genus 
Plasmodium that are transmitted by Anopheles mosquitoes. There are four species 
causing human malaria, Plasmodium falciparum, Plasmodium vivax, Plasmodium 
malariae and Plasmodium ovale. The simian malaria Plasmodium knowlesi has 
recently been recognized as the fifth species of Plasmodium causing malaria in human 
populations (Cox-Singh and Singh, 2008). P. falciparum and P. vivax are the most 
common causative agents and P. falciparum is the most lethal form. In 2004, P. 
falciparum was among the leading causes of death worldwide from a single infectious 
agent (WHO, 2008b).  
 
1.1. The life cycle of Plasmodium falciparum 
The human malaria Plasmodium spp have a complicated life cycle involving two 
hosts, and cycles between an asexual stage in the vertebrate host and a sexual phase in 
an insect vector (Figure 1.2). Sporozoites are initially transmitted to the human host 
through the bite of the female Anopheles mosquito. The parasites migrate to the liver, 
and penetrate hepatocytes where they undergo asexual division (exo-erythrocytic 
schizogony) to produce thousands of merozoites. P. vivax and P. ovale, at this stage 
can remain dormant as a hypnozoite form that can reactivate after symptomless 
intervals of up to several years after infection.  The merozoites enter the blood stream, 
and quickly invade red blood cells. The asexual reproduction of parasites in 
erythrocytes (schizogony) and the release of merozoites from infected red blood cells 
are responsible for the pathogenesis of the disease. P. falciparum develops 
approximately 48 hours inside the red blood cells, from ring stage (0-10 h post 
invasion) to the trophozoite (10 – 36 h post invasion) and the schizont stage (36 – 48 h 
post invasion) (Figure 2). During the erythrocytic schizogony, the parasite starts 
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several rounds of asexual division, resulting in mature schizonts (segmenters), each 
containing 16–32 daughter merozoites. Approximately 48 hours post invasion, 
infected erythrocytes rupture and free merozoites then can invade other red blood 
cells and continue the cycle of parasite multiplication, with extensive red blood cell 
destruction. In some case, the merozoites penetrate the red blood cell but do not 
divide, instead they differentiate into male and female gametocytes, which can live 
quiescently in the blood stream for weeks and be taken up by the mosquito. Once 
drawn into the mosquito, the gametocytes rapidly activate, fertilise to form the diploid 
zygote. After 18 to 24 hours, the motionless zygote becomes an elongated and motile 
ookinete. The short-lived ookinete moves between or through the midgut wall, and 
lies beneath the basement membrane, develops into oocyst. Through asexually 
multiplication, a large number of haploid sporozoites are formed. Eventually the 
oocyst ruptures and the sporozoites migrate to the salivary glands, ready for the next 
transmission cycle into the human host (Figure 1.2) (Dluzewski et al., 2008; Miller et 
al., 2002a). 
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Figure 1.1. Current distribution of indigenous malaria and the control status 
of the disease (WHO, 2008a). White area, malaria-free countries and/or no 
ongoing local transmission for over a decade. Gray area, malaria-endemic 
countries in phase of prevention of reintroduction. Alice blue area, malaria-
endemic countries in phase of elimination. Light blue area, malaria-endemic 
countries in phase of pre-elimination. Dark blue area, malaria-endemic countries 
in control program.  
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Figure 1.2. Life cycle of P. falciparum [adapted from (Winzeler, 2008)]. The 
infective sporozoites are dispensed from salivary gland of a female Anopheles 
mosquito into the human host. The sporozoites undergo schizogony in hepatocytes to 
produce thousands of merozoites which are released into the blood stream where they 
invade erythrocytes. The erythrocytic asexual cycles periodically complete and 
rupture the hosts to invade fresh red blood cells. Some merozoites differentiate into 
sexual gametocytes which, when ingested by the mosquito, initiate sexual 
development in the midgut, involving ookinetes and oocysts. The sporozoites inside 
the oocysts eventually migrate to the salivary gland, await transfer to the next 
vertebrate host.  
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Figure 1.3. The trophozoite stage of P. falciparum-infected RBC [adapted from 
(Tilley et al., 2008)]. Red compartment: RBC cytosol; yellow compartment: PV 
lumen; sky blue compartment: parasite. MC: Maurer’s cleft structure, TVN: 
tubulovesicular network, C: cytosome, A: Apicoplast, M: Mitochondrion. Some 
proteins inside the PV lumen are presented: PV1, SERA, PfSUB1 and some 
chaperones. VPCC: putative vacuolar protein-conducting channel within the PVM. 
Ca2+ 40µM: Ca2+ concentration in the vacuolar space. See text (1.4) for more details.  
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1.2. The parasite compartments  
Plasmodium belongs to the phylum Apicomplexa, a diverse group of unicellular 
protozoan parasites characterised by the presence of specialised secretory organelles 
at the anterior end of their invasive forms. These protozoa are pathogens of medical, 
veterinary and economic importance. The Apicomplexa phylum includes intracellular 
parasites of humans (Plasmodium, Toxoplasma, Cryptosporidium, Cyclospora, 
Isospora, Babesia), cattle (Theileria, Babesia, Neospora, Sarcocystis) and poultry 
(Eimeria).  
 
The merozoite: All apicomplexan parasites share features including presence of a 
specialised apical complex (after which the group is named), which is central to the 
invasion process. The erythrocytic invasive forms of Plasmodium – the merozoite, as 
well as other invasive forms, the sporozoite and insect ookinete, are highly polarized 
cells containing the apical complex at the apical end of the parasite (Bannister et al., 
2000). These organelles consist of the rhoptries, the micronemes, the apical polar ring, 
and the conoid [review in (Blackman and Bannister, 2001)]. The club-shaped 
rhoptries and the small, elongated micronemes are unique secretory organelles. They 
contain products required for motility, adhesion to host cells, invasion of host cells, 
and establishment of the parasitophorous vacuole (PV). The third secretory organelle, 
the spherical dense granules, present in all parts of the cytoplasm, are likely to be 
involved in the maturation of the PV [(review in (Mercier et al., 2005)]. In addition to 
the apical complex, apicomplexa have other exclusive structures, such as the 
apicoplast [(Köhler et al., 1997; McFadden et al., 1996; Wilson et al., 1996)], which 
may play an essential role in the synthesis of lipids, heme and isoprenoids (Waller and 
McFadden, 2005). Another unique feature of Apicomplexa is the pellicle, a composite 
structure consisting of the plasma membrane and the closely apposed inner membrane 
complex (IMC) (Lobo et al., 1999b). The pellicle is intimately associated with a 
number of cytoskeletal elements, including actin, myosin, microtubules, and a 
network of intermediate filament-like proteins [review in (Morrissette and Sibley, 
2002)].  
 
In the human blood stream, the parasite grows through different stages to gain 
nutrients and modify the host cell before escaping and invading new RBC. The 
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parasite undergoes numerous morphological changes throughout the life cycle [review 
in (Bannister et al., 2005)].  
The ring stage: After invasion, the parasite deforms into a thin biconcave disc 
(Langreth et al., 1978), thicker at the cytoplasm regions around the organelles 
nucleus, mitochondria, plastid, most of the ribosomes and endoplasmic reticulum 
(ER) while the center region is thinner because of less structures,  giving the ring 
shape in Giemsa staining blood smear. The parasite resides inside the newly formed 
PV within the RBC, start feeding itself with haemoglobin catabolism through the 
cytostome structure (Francis et al., 1997; Goldberg et al., 1990; Lobo et al., 1999b) as 
well as taking up other nutrients transported in from the plasma. As the ring stage 
enlarges, it begins to synthesise molecules specific to this stage (Spielmann and Beck, 
2000) and to extend the surrounding PV membrane (PVM) (Atkinson and Aikawa, 
1990; Elford et al., 1995). The ring eventually grows into the rounder trophozoite 
stage. 
The trophozoite: The difference between the ring and trophozoite stages depends on 
cell size and shape rather than any fundamental internal difference, and indeed the 
ring is more properly called the ring form of the trophozoite stage (Bannister et al., 
2005). This is the period of most active feeding, growth and red blood cell (RBC) 
modification by exporting various parasite proteins into the host cytoplasm. In 
Giemsa slides, trophozoites are characterised by its large, rounded shape and dots in 
the RBC cytosol, defined as Maurer’s clefts (Langreth et al., 1978; Wickert and 
Krohne, 2007a). There are also small knobs on the surface of the RBC (Atkinson and 
Aikawa, 1990). The membranous intracellular organelles also increase the size and 
the activity during growth (Bannister et al., 2005). The parasite continues feeding on 
haemoglobin, and the haem products of haemoglobin digestion are accumulated into a 
dark pigment, haemozoin, scattered within a large food (pigment) vacuole (Egan et 
al., 2002; Francis et al., 1997).  
The schizont: The parasite synthesises and assembles components that are needed for 
the next cycle of RBC invasion (Florent et al., 2004). About 16 nuclei are generated 
(the number may vary from 8 to 32 in a single schizont) (Margos et al., 2004) and 
these move into merozoite buds formed around the schizont's periphery (Bannister et 
al., 2005). The merozoites are not completely mature until short before the release 
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from the RBC. Finally, the merozoites are released in a protease-dependent process 
[(Yeoh et al., 2007), review in (Blackman, 2008)] and the free merozoites are ready 
for the next cycle.  
1.3. The parasite induces alterations of the human erythrocyte  
The mature human erythrocyte lacks a nucleus and other intracellular organelles, is 
devoid of de novo protein/lipid synthesis. Thus, as the parasite grows and replicates 
within the vacuole, it drastically remodels the host cell to the favour of its adaptation. 
These changes involve a range of morphological and physiological modifications of 
the erythrocyte, both to facilitate accessing to nutrients and causing adhesion of the 
infected RBC to the vascular endothelium [review in (Lingelbach et al., 2004; Plattner 
and Soldati-Favre, 2008)]. Structures unique to P. falciparum infected erythrocytes 
have been detected by detail via electron microscopy analyses, these include electron 
dense protein-containing structures on the surface of RBCs (the knobs) and several 
membranous structures – the Maurer’s clefts (MC) and the tubulovesicular network 
(TVN).  
 
1.3.1. Structural alterations 
1.3.1.1. Parasitophorous vacuole 
Many intracellular parasites reside and develop within vacuoles. The Leishmania 
passively enters their host cells via the phagocytic pathway and replicate within the 
phagolysosomes. In contrast, apicomplexan parasites such as Toxoplasma and 
Plasmodium actively invade the host cell. As a result, they reside within a 
parasitophorous vacuole (PV) which maintains a neutral pH [review in (Lingelbach 
and Joiner, 1998; Nyalwidhe et al., 2003)]. Such a safe niche confers resistance to 
some host cell defenses but significantly cuts the parasites off from host metabolites. 
These parasites have adopted different tactics to circumvent the problem, remodeling 
their vacuole to make it permissive to vital substances (Plattner and Soldati-Favre, 
2008). In case of the malaria parasite, the PVM forms a barrier between the infected 
RBC (iRBC) cell cytosol and the parasite surface. The vacuolar space represents a 
proteome which is clearly distinct from the erythrocyte cytosol and from the parasite 
cytosol (Nyalwidhe and Lingelbach, 2006).  
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1.3.1.2. The Maurer’s Clefts 
The membrane-bound compartment MC are the other major structural features seen in 
the cytoplasm of infected RBCs [review in (Wickert and Krohne, 2007b)]. Among 
proteins associated with the MCs are the skeleton-binding protein 1 [SBP-1, (Blisnick 
et al., 2000)], the membrane-associated histidine-rich protein [MAHRP, (Spycher et 
al., 2003)], the ring-exported proteins REX-1 (Hawthorne et al., 2004) and REX- 2 
(Spielmann et al., 2006), the repetitive interspersed family (RIFINS) (Petter et al., 
2007) and the subtelomeric variable open reading frame [STEVOR, (Przyborski et al., 
2005)]. The MCs play a role as a parasite-induced intermediate ‘sorting’ compartment 
for proteins destined to the erythrocyte membrane [review in (Lanzer et al., 2006; 
Przyborski, 2008; Wickert and Krohne, 2007b)].  
 
1.3.1.3. The tubulovesicular network 
The TVN projecting from the PVM to the red cell have been imaged by fluorescence 
microscopy (Behari and Haldar, 1994; Elmendorf and Haldar, 1993; Haldar et al., 
1989) and these studies suggest that the PVM and TVN are all interconnected 
compartments with other intraerythrocytic structures such as the Maurers clefts. The 
enlargement of the membrane most likely is due to metabolic processes by the 
parasite since mammalian erythrocytes do not synthesise lipids or proteins de novo 
(Lingelbach and Joiner, 1998). 
 
1.3.1.4. Knobs 
An important aspect in virulence of P. falciparum is the ability of infected 
erythrocytes to sequester in and obstruct the microvasculature of different organs 
(MacPherson et al., 1985). Cytoadhesion is mediated by the antigenically variant P. 
falciparum erythrocyte membrane protein-1 (PfEMP1) (Baruch et al., 1995; Hay et 
al., 2009; Kilejian, 1979; Su et al., 1995). PfEMP1 is concentrated on electron-dense 
elevations of the membrane termed as knobs (Luse and Miller, 1971; Trager et al., 
1966). The knob provides a platform for adherence under physiologic flow conditions 
(Crabb et al., 1997; Deitsch and Wellems, 1996). The other main component of knobs 
is the knob-associated histidine-rich protein (KAHRP) (Kilejian, 1979), and it 
contributes to altered mechanical properties of parasite-infected erythrocytes (Rug et 
al., 2006).  
.  
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1.3.2. Biochemical/ physiological alterations  
In addition to morphological and structural changes to the infected erythrocyte, the 
parasite alters the permeability of the RBC membrane (RBCM) to allow the uptake of 
nutrients, the removal of “waste” and volume and ion regulation of the infected cell 
(Ginsburg et al., 1983; Kirk, 2001). The increase of RBC permeability is attributable 
to the appearance in the membrane of 'New Permeation Pathways' (NPP) (Kirk, 
2001), thought to be one or more types of channels. Recently, the involvement of 
parasite encoded proteins in the generation of the pathways was reported, either as 
components of the pathways themselves or as auxiliary factors (Baumeister et al., 
2006). 
 
1.4. The parasitophorous vacuole- form and function 
1.4.1. Invasion of erythrocytes and the PV formation  
The invasion of erythrocytes by merozoites occurs rapidly (Cowman and Crabb, 
2006; Maier et al., 2006). The entire process of erythrocyte invasion takes about 30 s 
to 60 s and only about another 10 to 20 min to transform into an intracellular ring-
stage parasite (Dvorak et al., 1975; Mitchell and Bannister, 1988). Upon contact with 
an erythrocyte, the merozoite attaches and orients its anterior end towards the 
erythrocyte. The initial contact between the merozoite and erythrocyte is a crucial 
step, probably a random collision and presumably involves reversible interactions 
between proteins on the merozoite surface and the host erythrocyte (Bannister and 
Dluzewski, 1990). Primary attachment of the polar merozoite appears to occur at any 
point on the surface of this parasite stage. Several merozoite surface coat proteins 
have been described in this primary contact (Maier et al., 2006), largely comprised of 
glycosylphosphatidylinositol (GPI) anchored membrane proteins. The best 
characterised protein is the merozoite surface protein-1 (MSP-1), the most abundant 
protein on the merozoite surface. MSP-1 is essential for parasite survival, and is one 
of the major vaccine candidates (Holder et al., 1999; O'Donnell et al., 2000).  
 
The reorientation then occurs so that the apical end of the parasite is facing the 
erythrocyte membrane. A close association known as tight moving junction is formed 
between the merozoite and the host cell membrane, and the microneme contents are 
released at the same time (Aikawa et al., 1978; Aikawa et al., 1981; Bannister and 
Mitchell, 1989; Bannister and Dluzewski, 1990). The apical membrane antigen-1 
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(AMA-1) has been implicated to establish a key link between the weak initial contact 
involving MSPs and irreversible tight associations formed with microneme proteins 
(Alexander et al., 2006; Mital et al., 2005; Triglia, 2000). Two protein families, the 
Duffy binding-like (DBL) protein family (Camus and Hadley, 1985; Miller et al., 
2002a) and P. falciparum reticulocyte binding protein homolog (PfRh or PfRBL) are 
prime candidates for the adhessins in junction formation (Maier et al., 2006; Triglia et 
al., 2005). The motor factor(s) in Plasmodium merozoites have not been specifically 
identified, but in sporozoites that invade liver cells, thrombospondin-related 
anonymous protein (TRAP) appears to provide the crucial link (Morahan et al., 2009; 
Sultan et al., 1997).  
 
The entry phase of merozoite invasion into erythrocyte is an active process by the 
parasite since the mature RBC is not capable of either phagocytosis or receptor-
mediated endocytosis. Ultrastructural studies show that upon the forming of the 
junction, the merozoite moves toward the apical end and a membrane-line invasion 
pit, the PV, begins to form beyond the boundaries of the junctional bands and the 
roptry constituents are discharged into the PV (Aikawa et al., 1978; Aikawa et al., 
1981; Bannister and Mitchell, 1989; Sam-Yellowe et al., 1988). These ultrastructural 
observation, together with proteomic data (Sam-Yellowe et al., 2004) indicate that the 
rhoptries components participate in formation of the PVM and the PV [review in 
(Galinski et al., 2005; Lingelbach and Joiner, 1998)]. 
 
Invasion ends with a sequence of further changes. First, the PV is sealed off by the 
fusion of the RBC membrane across the mouth of the pit, and the PVM also seals and 
detaches from the RBC surface. Second, the dense granules (DG) move to the 
merozoite surface and fuse with it to release their contents into the PV, causing the 
further expansion of the PVM (Aikawa et al., 1978; Bannister and Dluzewski, 1990). 
Ring-infected erythrocyte surface antigen (RESA), the first indentified dense granule 
protein (Aikawa et al., 1990), was detected to release from merozoite DG after 
erythrocyte invasion  (Culvenor et al., 1991).  
 
The biochemical composition and molecular process of the PVM formation remain 
unclear, but recent studies of both Plasmodium and Toxoplasma are opening some 
answers. Whatever the mechanism, it is clear that the RBC membrane is modified at 
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the point of invasion, and that secretion from the merozoite rhoptries is largely if not 
wholly responsible for the changes. For the lipid part of the PVM, host cell membrane 
lipids are substantially involved in PVM formation (Hakansson et al., 2001; Haldar 
and Uyetake, 1992; Pouvelle et al., 1994; Ward et al., 1993). But the composition is 
somewhat unexpected when Phosphatidylinositol - 4,5 - bisphosphate, a major 
phosphoinositide in erythrocyte membranes, was found excluded from the PV 
(Murphy et al., 2007), thus providing the first evidence for erythrocyte phospholipid 
remodeling by the parasite. Analysis of detergent resistant microdomains (DRM) 
obtained from a total membrane fraction of infected erythrocytes (iRBC) also revealed 
several host proteins in the PVM, including flotillins-1 and -2, aquaporin-1, 
scramblase (Murphy et al., 2004) and most recently, aquaporin-3 (Bietz et al., 2009). 
However, whereas a host cell DRM-associated stomatin, band 7, is excluded from the 
PVM, a parasite stomatin in rhoptry DRM rafts and the parasite RhopH proteins enter 
the vacuole (Hiller et al., 2003). The mechanism of these events clearly requires the 
participation of both host- and parasite-derived factors.  
 
1.4.2. The PV – a transit compartment 
Mature erythrocytes are devoid of trafficking machinery or organelles and, therefore, 
the parasites must set up and regulate protein transport within the erythrocyte 
cytoplasm to mediate the uptake of nutrients from the host bloodstream, in addition to 
displaying parasite-encoded proteins on the erythrocyte surface (Charpian and 
Przyborski, 2008; Cooke et al., 2004). To reach the host cell cytosol or surface, 
parasite proteins must passage across both the parasite plasma membrane (PPM) and 
the PVM.  
 
Trafficking of proteins to the PV is similar to the classical pathway of higher 
eukaryotes, with proteins entering the endoplasmic reticulum (ER), based on an N-
terminal ER targeting signal (Adisa et al., 2003; Benting et al., 1994; Wickham et al., 
2001). Some proteins, such as the serine-rich antigen (SERA) family, remain in the 
vacuolar lumen (Delplace et al., 1988; Knapp et al., 1989), whereas other proteins, 
such as KAHRP are directed outwards across the PVM (Wickham et al., 2001). 
Earlier studies evidenced that soluble parasite proteins destined for the host 
erythrocyte pass transiently through the lumen of the PV before being secreted into 
the red blood cell (Ansorge et al., 1996; Baumeister et al., 2001). Later publications 
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reported that those exported parasite proteins require a conserved motif (RxLxE/Q/D), 
termed the Plasmodium export element (PEXEL) or Host Cell Targeting (HCT)/ 
Vacuolar Targeting Sequence (VTS), for targeting beyond the PVM into the host cell 
(Hiller et al., 2004; Marti et al., 2004). PEXEL appears to be cleaved within the 
parasite’s ER. The “new” n-terminus of the protein is then acetylated (Boddey et al., 
2009; Chang et al., 2008). The machinery involved in protein transport across the 
PVM is poorly understood.  It has previously been reported that PEXEL-containing 
chimaeras within the PV have the appearance of a necklace of beads that are resistant 
to recovery after photobleaching, suggesting the presence of subcompartments within 
the vacuole (Adisa et al., 2003; Wickham et al., 2001). These compartments may 
house factor(s) that identify and translocate proteins trafficked there. Latest evidence 
reported that soluble proteins must cross the PVM into the erythrocyte cytoplasm in 
an unfolded state, strongly supporting the existence of a vacuolar protein-conducting 
channel (VPCC) within the PVM (Gehde et al., 2009).  
 
1.4.3. The PV – nutrition acquisition and regulation of the ionic environment 
Apart from being a protein sorting compartment, the PV is also postulated to play a 
role in nutrient acquisition (Lingelbach and Joiner, 1998). Plasmodium ingests 
approximately 80% of the host cell haemoglobin for its amino acid supply and to 
provide “space” for the growing parasite cell (Lew et al., 2003). The cytostome 
structure (see 1.2 above) constantly phagocytoses the PVM including haemoglobin 
and transport to the food vacuole where the haemoglobin is digested. Those poorly 
represented amino acids (cysteine, methionine, and glutamine) or absent (isoleucine) 
in human haemoglobin or other essential nutritive materials must be uptaken from the 
external environment. The proposed mechanisms of acquisition might be from the 
NPP (Kirk and Saliba, 2007)(see 1.3 above). Electrophysiological and biochemical 
studies have shown that the PVM contains nonselective pores that allow passive 
bidirectional movement of small molecules up to 2000 Da (Desai and Rosenberg, 
1997; Kirk, 2001; Nyalwidhe et al., 2002).  
From the molecular sieve feature of the PVM, the ionic composition of the PV is 
expected to be very similar, if not identical, to the cytoplasm of the erythrocyte. 
However, if the vacuolar space contains the same ionic environment as RBC cytosol, 
the parasite faces critical survival problems. In common with other mammalian cells, 
the erythrocyte cytoplasm maintains high K+ concentration (140 mM) and very low 
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Ca2+ (100 nM), clearly in contrast to that of regular extracellular medium in most cells 
(Alleva and Kirk, 2001). Regarding Ca2+, eukaryotic cells normally need an 
extracellular Ca2+ concentration close to millimolar range. Plasmodium parasite 
cleverly overcomes the problem by the maintenance of a high Ca2+ concentration 
within the PV (Gazarini et al., 2003). The [Ca2+] within this compartment was found 
to be around 40 µM, sufficiently high to be compatible with a normal loading of the 
Plasmodia intracellular Ca2+ stores (100 – 1,000-fold higher than that in the parasite 
and RBC cytoplasm respectively). The authors also demonstrated experimentally that, 
if the Ca2+ concentration in the PV was reduced, the maturation of the parasites was 
impaired, and eventually is incompatible with the survival of the Plasmodia within the 
RBC. The sequencing of the Plasmodium genome (Gardner et al., 2002) and several 
recent studies have identified in this parasite a number of signaling molecules related 
to those of vertebrate cells, including many proteins concerned with Ca2+ handling and 
signaling [review in (Garcia et al., 2008)]. The key question addressed here is to 
identify factors involving in the Ca2+ homeostasis and the Ca2+-based signaling 
mechanisms, with the PV as a Ca2+ reservoir outside of the parasite plasma 
membrane.  
 
 
1.4.4. The PV – preparation of merozoite egress 
To invade the host cell, the parasite must firstly initiate egress from its infected cell, 
and this process involves disruption the PVM and the host cell membrane. It was 
observed that egress is a rapid, and therefore, by inference, highly regulated event 
[review in (Blackman, 2008)]. The mechanism and the temporal sequence of PVM 
and host cell membrane rupture are not well understood. Live microscopy and 
selective inhibitor studies have revealed that P. falciparum merozoite egress is a two-
step process, but whether the PVM or the host cell membrane ruptures first is still 
much on debate (Glushakova et al., 2005; Soni et al., 2005; Wickham et al., 2003). 
Recent work by Heussler and colleagues in liver stage merozoites has revealed some 
important parallels with the blood stage egress. The observation, very clearly 
detectable in these relatively large cells, has agreed with the work from Wickham et 
al. in which the PVM breakdown precedes RBC membrane rupture (Sturm et al., 
2006; Sturm and Heussler, 2007; Wickham et al., 2003). 
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Whatever the sequence of membrane rupture is, various publications evidenced that 
the egress requires protease activity. Treatment of the cultures of P. falciparum 
asexual blood stages parasites with a range of protease inhibitors, such as a mixture 
of leupeptin, chymostatin, antipain (a serine and cysteine protease inhibitor), E64 
(cysteine protease inhibitor), pepstatin (an aspartic protease inhibitor) resulted in the 
blocking of merozoite egress  [review in (Blackman, 2008)]. Nevertheless, at least 
three common conclusions can be drawn from the accumulated data: that breakdown 
of the PVM and host cell membrane is differentially regulated; that both events are 
protease-dependent; and that PVM rupture is an E64-sensitive process. Given the 
high specificity of E64 for cysteine proteases, this strongly implicates the 
involvement of one or more cysteine proteases in PVM rupture, and at least one 
additional distinct activity in host cell membrane rupture. Members of the SERA, a 
family of nine genes in P. falciparum, are one of the best potential mediators of 
egress.  
 
The SERA proteins are most highly expressed at schizont stage and localize to the 
PV lumen (Delplace et al., 1987; Delplace et al., 1988; Knapp et al., 1989; Knapp et 
al., 1991; Miller et al., 2002b), putting them in the right place and at the right time to 
take part in egress. All the SERA gene products share a central relatively conserved 
papain-like domain as well as N- and C-terminal regions that contain a number of 
conserved Cys residues (Miller et al., 2002b). SERA5 and SERA 6 are most 
abundantly transcribed and translated. Early studies also marked a close temporal 
association between the proteolytic processing of SERA5 and blood-stage egress 
(Delplace et al., 1987; Delplace et al., 1988). The processing of SERA5 was shown 
to be mediated by a subtilisin-like serine protease called PfSUB1 (Blackman et al., 
1998; Sajid et al., 2000; Yeoh et al., 2007). Using a transgenic parasite line 
expressing epitope-tagged PfSUB1, Yeoh and colleagues showed that PfSUB1 was 
expressed in an unusual set of dense granule-like organelles (exonemes) from which 
it is released, in a fully soluble form, into the PV space just prior to egress (Yeoh et 
al., 2007). A selective PfSUB1 inhibitor prevented egress and also blocked SERA5 
processing, suggesting a link between these events. Moreover, upon its release into 
the PV, PfSUB1 directly mediates the primary proteolytic processing of  three major 
proteins on the merozoite surface, MSP1, MSP6 and MSP7 (Koussis et al., 2009). 
Thus the PV contain factor(s), so far PfSUB1, which regulate both egress and 
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proteolytic remodelling of the developing merozoite in preparation for its release 
from the infected cell. 
In addition to parasite-derived proteases activity in parasite egress, the latest work on 
P. falciparum and Toxoplasma reveals that both parasites hijack host cell calcium-
regulated calpain protease to facilitate their escape from infected cells 
(Chandramohanadas et al., 2009). The authors suggest a model involving calcium 
signal triggered late in the development stages. Once again, it raises the question of 
how the parasite regulates Ca2+-based signaling mechanisms (see 1.4.3 above). As a 
distinct compartment from both the parasite and the host cell cytosol, the PV resident 
proteins would have unique features and functions, waiting for further research.  
 
Generally, the function of gene products can be explored by experimental approaches 
that involve in the knocking-out of individual or several genes. A major limitation in 
determining the function of genes in Plasmodium has been the inability to genetically 
manipulate this parasite with ease. Also, classical genetics studies in P. falciparum are 
limited due to the difficulties in creating genetic crosses (Walliker et al., 1987). 
Nevertheless, the generation of knock-out P. falciparum parasites has been 
successfully applied and enabled researchers to study phenotypic changes.  
 
1.5. Genetic manipulation of P. falciparum 
The malaria parasite represents a unique challenge for transfection because the 
introduced DNA must cross multiple membranes before it can enter the parasite 
nucleus, including those of the RBC, the parasitophorous vacuole, the parasite and the 
nucleus itself. Therefore, although the in vitro culture system of P. falciparum has 
been used widely for many years (Trager and Jensen, 1976), transfection of the 
parasites remained elusive despite intensive efforts. Transfection of malaria parasites 
was first performed transiently in the sexual stages of the bird malaria parasite P. 
gallinaceum (Goonewardene et al., 1993). It was not until 1995 that Wu and 
colleagues performed the transient transfection in the human malaria parasite P. 
falciparum (Wu et al., 1995) and van Dijik first reported the stable transfection in 
Plasmodium, using the model organism of rodent malaria P. berghei (van Dijk et al., 
1995). Soon after, the similar system demonstrated at last that P. falciparum within 
erythrocyte can be successfully modified by integrative transfection (Crabb and 
Cowman, 1996; Wu et al., 1996). Despite the low efficiency of the P. falciparum 
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transfection, these crucial breakthroughs shed new light to malaria research, widened 
studies of many aspects for understanding Plasmodium biology and malaria 
pathogenesis in molecular terms.  
 
1.5.1. Difficulties with P. falciparum transfection 
Unlike many other systems, including the rodent malaria parasite P. berghei, P. 
falciparum can only take up the circular plasmid DNA, with a very low efficiency in 
the range of 10-6 (O'Donnell et al., 2002), compare to the efficiency of P. berghei (~ 
103 – 104). The low competence is primarily related to the requirement of performing 
the transfection at the intracellular ring stage of the blood stage cycle. Hence, the 
exogenous DNA must cross the four layers of membranes before reaching the 
nucleus. The transfection efficiency in P. berghei is, however, much higher due to the 
transfection directly into the freely extracellular merozoites, avoiding the multilayers. 
P. falciparum extracellular merozoites have a short half-life and to date, there is no 
method to prepare sufficient viable P. falciparum merozoites alone, not to mention for 
use in transfection. 
 
Another major obstacle is the extremely rich A/T content of P. falciparum DNA 
sequences, which leads to difficulties in cloning steps in Escherichia coli. The AT 
composition of the extragenic region of P. falciparum genes can be higher than 90%. 
For most of stable transfections, vector constructs are quite large, containing both the 
ampicillin resistance marker for selection in E. coli and selectable marker cassette in 
Plasmodium, as well as the targeting sequence. The plasmid constructs are highly 
unstable and poorly yield, often end up in extensive recombination state. The cloning 
steps might take several months and are labor consuming with a need to screen large 
numbers of E. coli colonies to identify those that contain the correct plasmids in an 
unrearranged state.   
 
Another complication of P. falciparum transfection is their ability to maintain 
transfected plasmids as stable episomal replication form (SRFs) under the pressure of 
drug selection (Kadekoppala et al., 2001; O'Donnell et al., 2001). These SRFs are 
large concatamers of the parental plasmids, comprising at least nine plasmids in a 
head-to-tail array. Subsequently, the plasmid integration into a specific chromosomal 
locus is achievable in P. falciparum but the methods are slow and laborious [reviewed 
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in (Crabb et al., 2004)]. This problem can be circumvented by double homologous 
recombination and removal of episome-containing parasites, using negative selection 
system of marker thymidine kinase (TK)  (Duraisingh et al., 2002) (Figure 1.4). 
 
The stable transfection in Plasmodium is also restricted by the limited number of 
positive selectable markers. The two most commonly used selectable markers are a 
modified Toxoplasma gondii dihydrofolate reductase-thymidylate synthase gene 
(DHFR-TS) (Wilson et al., 1996), confers resistance to pyrimethamine and the human 
DHFR gene (hDHFR) which resists to the experimental antimalarial drug WR99210 
(Fidock and Wellems, 1997). Three other positive selectable markers have been 
successfully used in P. falciparum selections, including blasticidin S deaminase 
(BSD) (Mamoun et al., 1999), neomycin phosphotransferase II (NEO) (Mamoun et 
al., 1999) and puromycin-N-acetyltransferase (PAC) (de Koning-Ward et al., 2001), 
encode resistance to blasticidin, geneticin (G418) and puromycin, respectively.  
 
1.5.2. Functional analysis by integrative transfection 
At the moment applying the RNAi technique might not be possible in Plasmodium, 
mostly due to the absence of  RNAi pathway ortholog in any of the available 
Plasmodium databases [review (Militello et al., 2008)], thus, genetic studies of gene 
characterisation in this parasite mainly depend on introducing exogenous DNAs by 
transfection techniques, either by transient or stable transfection.  
 
1.5.2.1. Gene targeting by single-crossover  
The advancement of stable transfection and homologous recombination in 
Plasmodium has allowed direct studies on malaria protein function. In T. gondii, 
integration into the genome occurs preferring non-homologous over homologous 
recombination, leading to efficient insertional mutagenesis (Roos et al., 1997). 
However, if  the length of the homologous sequence is sufficient (2-3 kb), double 
cross-over in T. gondii is favourable (Wilson et al., 1996). In contrast, integration in 
the Plasmodium system is almost exclusively homologous, and as little as 250 – 300 
bp of targeting sequence is effective enough for the integration (Lobo et al., 1999a). 
The Plasmodium genome is haploid and integration of transfected DNA into the 
Plasmodium genome occurs by homologous recombination (Crabb and Cowman, 
Introduction 
  
 19 
1996). This has provided a capable system for manipulating the Plasmodium genome 
by gene disruption or allelic replacement. 
 
1.5.2.2. Gene targeting by double-crossover homologous recombination 
using negative selection marker 
Despite the ability to disrupt many genes, there are at least two big disadvantages to 
knockout by single-crossover integration. First, after integration, the plasmid 
backbone is still maintained at the site of the gene locus, making it challenging to 
knock out a second gene, using a different selectable marker, as the second integration 
event would be favored the first integrated plasmid backbone over the desired locus 
(Cowman and Crabb, 2005). The existence of the plasmid backbone can also lead to a 
potential reversion event by looping the plasmid back out from the genome, 
generating plasmids that could segregate during schizogony. Although it is rare, 
reversion has been previously reported in P. berghei (de Koning-Ward et al., 2000; 
Sultan et al., 1997). Furthermore, the single-crossover recombination can result in 
truncated proteins with a potential dominant negative effect as demonstrated with 
PfEMP3 (Waterkeyn et al., 2000). Secondly, the time required to obtain integrants by 
single-crossover incident is prolonged due to the persistence of the circular episomal 
plasmids. It takes 2 to 3 weeks for the integration of linear DNA into P. berghei 
chromosomes but at least 3 months to select the integration of circular plasmid DNA 
in P. falciparum (Crabb et al., 1997; Crabb et al., 2004). The parasites containing 
integrated plasmid have to compete with the parasites with episomal form. The 
episomal plasmid containing parasites possibly grow faster, limiting the selection of 
homologous recombination parasites. In some cases it is impossible to isolate 
parasites with gene disruptions that result in decreased growth rates. To isolate 
integrated parasites, a growth on and off drug cycling can be applied. Episomal 
plasmids are segregated non-evenly into daughter merozoites (O'Donnell et al., 2001; 
van Dijk et al., 1995), resulted in some cells obtaining many plasmid copies whereas 
others are plasmid deficient. In contrast, integrated plasmids will be equally 
distributed into daughter merozoites. Removal of drug selection will rapidly lead to 
the loss of episomal plasmids, and re-introduction of drug pressure after a period 
would select for parasites with integrated events (Cowman and Crabb, 2005). Thus, 
the strategy of on-and-off drug cycling, however time consuming, has still been the 
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conventional method for selecting parasites with single-crossover homologous 
recombination.  
 
To overcome the disadvantages of single-crossover strategy, the rare double-crossover 
event has been recovered by use of a negative selection marker (Duraisingh et al., 
2002). Negative selection relies on the expression of a foreign gene in a cell that 
converts a normally harmless drug into a toxic one. The thymidine kinase (TK) gene 
from Herpes simplex virus is an enzyme that activates nucleoside analogues such as 
ganciclovir into a toxic metabolite which inhibits the de novo pyrimidine biosynthesis 
pathway and DNA synthesis directly. The TK gene was used together with the 
positive selectable marker hDHFR to create positive/negative selection systems. The 
positive selectable marker was flanked by the two homologous regions of target 
sequence. Under the pressure of positive and negative selection, parasites containing 
episomal plasmids are resistant to WR99210 but susceptible to ganciclovir. The only 
survival parasites were those with integration by double-crossover recombination, 
deleting the negative selection cassette as well as the plasmid backbone, and 
incorporating the positive selectable marker into the locus of interest on the 
chromosome, generating the knockout line. Duraisingh et al. had also tested the 
ability of using the E. coli cytosine deaminase (CD) enzyme in negative selection. CD 
converts the prodrug 5-fluorocytosine (5-FC) into the 5-fluorouracil (5-FU) toxic 
form, inhibits RNA synthesis as well as the thymidylate synthase. However, at the 
time of experiment, the E. coli CD system was not successful as it resulted in mutant 
P. falciparum parasites resistant to the effect of the 5-FC metabolite.   
While the double-crossover recombination by negative selection strategy using the 
TK enzyme has now become the main approach to knockout genes in P. falciparum, 
the system itself has been reported not potent enough. In some cases, parasites with a 
single copy of the plasmid integrated via single-crossover recombination could still 
survive in high concentration of ganciclovir (Duraisingh et al., 2003b; Maier et al., 
2003). The possible reason was the lack of sufficient TK expression from one copy of 
the gene, allowing some parasites to survive. A more potent negative selection system 
is required. The yeast fusion protein yCDUP from Saccharomyces cerevisiae CD 
(ScCD) and uracil phosphoribosyl transferase (ScUPRT) were recently successfully 
applied for positive-negative selection in P. falciparum (Maier et al., 2006) and 
shown to be very effective for double-crossover. However, the concentration of the 
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prodrug 5-FC must be in control because no parasites were obtained after selection 
with more than 1µM of 5-FC. This was likely because of the “bystander effect”, 
where ScCDUP expressing parasites metabolise the prodrug 5-FC to the toxic 
metabolite 5-FU which could diffuse into the non-ScCDUP containing parasites, 
resulting in growth inhibition and killing them. In the TK or E. coli CD negative 
selection system, this “bystander effect” was also observed  (Duraisingh et al., 2002).  
 
Despite the shortcomings of the TK-negative selection vector, the system has been 
very useful in knockout studies in P. falciparum, including those genes which were 
not able to be disrupted previously by single-crossover strategy (McCoubrie et al., 
2007). The application of gene disruption by double-crossover recombination was 
taken to a new level by a large scale gene knockout approach with functional 
characterisation of 83 parasite proteins that are potentially exported out of the PV 
into the host erythrocyte (Maier et al., 2008). The work was initially started with 
pHTK vector (Duraisingh et al., 2002), and further improved by ScCDUP system 
(Maier et al., 2006). In the study they were able to disrupt 53 of 83 genes by double-
crossover homologous recombination. For the rest 30 genes, the transfection was 
successful but not the integration. While the inability to select the integrated form for 
some genes is not a convincing proof that they are essential under laboratory 
conditions, it is consistent with the suggestion that they might play important 
functions in growth of the erythrocyte stage parasites. This study significantly 
extends our understanding of the role of exported proteins in host/parasite 
interactions being essential for survival of P. falciparum in vivo and defines a group 
of potentially novel therapeutic targets. 
 
While gene disruption is an important technique to address protein function, there are 
essential genes which are impossible to knockout; gene targeting for allelic 
replacement via single-crossover recombination has become an important tool. This 
technique is particularly useful in studying the role of mutations in drug resistance; 
especially when targets are essential genes and the modification of amino acids 
would not disrupt the sequence and function of proteins. Allelic replacement has also 
been applied to address the role of antibodies in immunity or to identify 
polymorphisms  [for review see (Cowman, 2005)].  
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Figure 1.4: Schematic representation of single (A) and double (B) crossover 
homologous recombination in P. falciparum. (A) The insertion construct contains a 
selection cassette (sphere box, M) and a fragment of the targeting sequence (wide upward 
diagonal box). The targeting sequence could either be at the 5’ or 3’ end of the target 
gene (solid box), here is shown the scheme of the 5’-end single crossover. (B) Double 
crossover with the pHTK vector. The hDHFR cassette is flanked by the two homologous 
regions of the targeting sequence. The plasmid backbone (dashed line) also contains the 
Thymidine kinase cassette (TK, dot box) for negative selection. See text for more details. 
WT: target locus of wild-type parasite, ∆ prediction of the integrated locus.  
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1.5.3. Other gene technique advances in P. falciparum  
Although insight into malaria protein function has been achieved through the gene 
disruption by homologous recombination, the technique cannot be applied in 
essential genes. The only way to control the expression of essential genes, in the 
haploid organism P. falciparum, is to regulate the gene expression system, which has 
not been described until recently. The first conditional expression system in P. 
falciparum was based on the Anhydrotetracycline (ATc)- inducible system (Meissner 
et al., 2005). However, because of its complicated system and the time-consuming 
procedure, the method has not been widely applied.  
Most recently several methods have been developed, including the ribozyme-based 
system (Agop-Nersesian et al., 2008). The ribozyme was placed at the translational 
start region of the gene of interest, leading to cleavage of mRNA and its degradation. 
RNA self-cleavage can be controlled by specific inhibitors of ribozyme activity, 
keeping the mRNA stable and hence, its translation. In principle, embedding this 
regulation system into any locus allows placing the gene of interest under the control 
of its endogenous promoter to ensure the right timing of expression. The method is 
still a newborn technique and in the process of finding specific and harmless 
ribozyme inhibitors to prevent the cells from toxic effects. 
Another strategy is the post-translational regulation by a destabilization domain 
technology (Armstrong and Goldberg, 2007). This method prevents proteins from 
degradation by adding Shield-1, a permeable small molecule ligand of the human 
rapamycin-binding protein FKPB12. The ‘destabilization domain’ of FKPB12 is 
fused to the N- or C-terminus of the target protein, thereby facilitating its 
degradation. However, the destabilization domain technology has not been developed 
for secreted proteins yet. The latest advancement is the co-regulated transgene and 
bsd selectable marker by a bidirectional promoter (Epp et al., 2008).  
 
In P. berghei, tool for functional analyses of essential genes have been achieved by 
the Flp/FRT site-specific recombination (Carvalho et al., 2004). A site-specific 
recombination system has also been developed in P. falciparum, using the 
mycobacteriophage Bxb1 integrase (Nkrumah et al., 2006). The Bxb1 system offers a 
method to complement gene function but currently the system is of no advantage for 
available gene knockout lines as these do not contain the required site-specific attB 
and attP site.  
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With more than 60% of the genome coding for hypothetical proteins (Gardner et al., 
2002), the conventional one-by-one knockout procedure is not strong enough for the 
study of protein function. Tools to identify essential genes in malaria parasites 
require high-throughput screening selection. Only until recently have the transposon 
based mutagenesis been developed, allowing functional genomic studies to be 
performed proficiently. In P. berghei that was the shuttle transposon mutagenesis 
system, using a mini Tn5 transposon derivative (Sakamoto et al., 2005). In P. 
falciparum, it was developed by Balu et al, using the piggyback transposable 
elements (Balu et al., 2005). This is the first system that allows widespread, random 
and direct integration with high efficiency into the P. falciparum genome. Currently 
the system has only been tested the transiently expressed transposase therefore a large 
scale screening has not achieved (Balu et al., 2005).  
 
1.6. PfPV1 – a novel parasitophorous vacuole protein  
 
In order to identify and characterise the vacuolar proteins that are involved in various 
processes, we have begun to analyse the PV’s proteome (Nyalwidhe et al., 2002; 
Nyalwidhe and Lingelbach, 2006). Proteins of the PV fall into the following main 
classes: chaperones, proteases, and metabolic enzymes, consistent with the expected 
functions of the vacuole (Nyalwidhe and Lingelbach, 2006). From the proteomic data, 
we identified a protein which was named PfPV1 for which no functional annotations 
are available. The encoding gene PF11_0302 on chromosome 11 contains no intron 
and expresses a product of 452 amino acids. PfPV1 has a theoretical pI of 4.97 and 
molecular mass of 51951.49 Dalton [from PlasmoDB, (Aurrecoechea et al., 2009)]. 
The protein is predicted to have an N-terminal signal sequence and the cleavage site is 
between position 21 and 22: IYG- NV  (Bendtsen et al., 2004). The PfPV1 gene had 
been evidenced to be expressed at all stages of the intraerythrocytic development 
(Bozdech et al., 2003b; Le Roch et al., 2003). The latest update from PlasmoDB has 
also reported peptide sequences of PfPV1 found in purified merozoite proteomics 
[PlasmoDB, (Aurrecoechea et al., 2009)] and gametocyte and ookinete stages 
(Aurrecoechea et al., 2009). 
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1.7. Objective 
 
While it is reasonable to speculate that vacuolar membrane shelters the parasite in a 
potentially hostile environment, there are much more to the biological function of this 
particular compartment. The aim of this study is to characterise PfPV1 protein by 
reverse genetic approaches. The generation of knock-out parasites will enable us to 
test whether the respective gene is essential and, if their deletion results in viable 
parasites, it will enable us to study phenotypic changes. The recombinant protein 
fused to GST or 6x His-tag expressed in E. coli is also studied to further proceed in 
pull down assays to identify interacting patterns. 
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Figure 1.5: PfPV1, a conserved hypothetical protein encoded by PF11_0302. (A), 
Genome browser of PF11_0302 gene (GenBank: XM_001347937) on chromosome 
11 (graphic from NCBI). The neighbouring genes PF11_0300, PF11_0301 and 
PF11_0303, PF11_0304 were also displayed on the map. (B), Peptides of PfPV1 were 
detected from mass spectrometry data of free merozoites (Aurrecoechea et al., 2009). 
(C), Protein features of PfPV1, graphic from PlasmoDB 4.4. (D), Expression profile 
of PF11_0302 gene, data from glass slide oligo array (Bozdech et al., 2003a) on 3 
different P. falciparum strain: HB3, 3D7 and Dd2, color specific for each strain as 
depicted on the graphic; y-axis, averaged smoothed normalized log (base 2) of 
cy5/cy3 for PF11_0302. (E), Expression profile of PF11_0302 based on data from 
photolithographic oligo array (Le Roch et al., 2003), color specific for studies on 
Sorbitol- or Temperature-synchronized 3D7 strain parasites as depicted on the 
graphic; y-axis, log (base 2) ratio of Affymetrix MOID expression value (normalized 
by experiment) to average MOID value for all time points for a gene. (F), Expression 
intensity percentile, the y-axis gives the percentile of PF11_0302 gene expression 
intensity in the spectrum of all other genes’expression intensities for that time point. 
For all (D), (E) and (F), x-axis is time in hours post invasion. (G), Expression value of 
PF11_0302 normalized by Affymetrix MOID experiment (Le Roch et al., 2003). 
Graphs of (D) – (G) were from PlasmoDB 5.5 (Aurrecoechea et al., 2009).  
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2. Materials and Methods 
2.1. Materials 
2.1.1. Equipment 
 
Agarose gel chambers Gibco BRL, Neu-Isenburg 
Autoclave 3870ELV  Tuttnauer 
Biofuge fresco Heraeus, Hanau 
Biofuge pico Heraeus, Hanau 
Blotting apparatus Phase, Lübeck 
BD FalconTM centrifuge tube Sarstedt, Nümbrecht 
Centrifuge 5804R Eppendorf, Hamburg 
Centrifuge mikro 22R Hettich Zentrifugen, 
Digital camera EDAAS 120 Kodak, Japan 
Drying machine Heraeus, Hanau 
Eppendorf reaction tubes Eppendorf, Hamburg 
Erlenmeyer flask Kobe, Marburg 
Exposition cassettes Rego, Augsburg 
Flow Hera safe Heraeus, Hanau 
Gene-Pulser II BIO-RAD, UK 
Glass slides IDL, Nidderau 
Hybridization oven 6/12 UniEquip, Leipzig 
Ice machine AF-20 Scotsman 
Incubator shaker G25 New Brunswick Scientific, USA 
Macintosh power PC 7500/100 Apple Macintosh, USA 
Magnetic bubbler Combimag RCH IKA, Staufen 
Medical X-Ray film Fuji, Japan 
Nitrocellulose membrane Schleicher & Schuell, Dassel 
Nylon hybridisation membrane, Hybond-N+ GE Healthcare, UK 
Pasteur pipettes COPAN, Italy 
PCR reaction tubes Sarstedt, Nümbrecht 
Personal cycler Biometra, Göttingen 
pH-meter 766 Calimatic, Mering 
Pipette tips Greiner, Frickenhausen 
Plastic petri dishes Greiner, Frickenhausen 
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Plastic pipettes Greiner, Frickenhausen 
Power supply 2103 LKB Biochrom, USA 
Printer stylus photo 700 Epson 
Uno-Thermoblock Biometra, Göttingen 
Vortexer Reax 2000 Heidolph, Schwabach 
Waterbath Köttermann, Uetze/Hänigsen 
Weighing machine 1205 MP Sartorius, Göttingen 
Weighing machine P1200 Mettler, Gießen 
Whatman-paper Schleicher & Schuell, Dassel 
 
2.1.2. Chemicals 
 
Agarose low EEO Roth, Karlsruhe 
Ampicillin Roth, Karlsruhe 
Ammoniumpersulfat (APS) Roth, Karlsruhe 
Albumax Invitrogen, Groningen 
Bromophenol blue Merck, Darmstadt 
Calcium chloride Roth, Karlsruhe 
Carbenicillin Roth, Karlsruhe 
Chloroform Merck, Darmstadt 
Cresol red Sigma, Taufkirchen 
[alpha-P32]Deoxyadenosine 5’-triphosphate  
([alpha-P32]dATP) Hartmann Analytic, Braunschweig 
DNA labeling kit, HexaLabel Plus Fermentas, Germany 
Deoxyribonucleic acid type III Sigma-Aldrich, Schnelldorf  
Diethyl pyrocarbonate (DEPC) Fluka, Neu-Ulm 
Dimethyl sulphoxide (DMSO) Fluka, Neu-Ulm 
1,4-dithio-DL-threitol (DTT) Fluka, Neu-Ulm 
Di-potassium phosphate Roth, Karlsruhe 
Ethanol p.a. (EtOH) Applichem, Darmstadt 
Ethidiumbromid (EtBr) Sigma, Taufkirchen 
Ethylendiamintetra-acetic acid (EDTA) Sigma, Taufkirchen 
Ethylene glycol-bis-(beta-aminoethylether) 
N,N,N´,N´-tetra acetic acid (EGTA) Roth, Karlsruhe 
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Glucose Merck, Darmstadt 
Guanidine hydrochloride Roth, Karlsruhe 
Glycine Roth, Karlsruhe 
Glycerol Applichem, Darmstadt 
Hydrogen peroxide Fluka, Neu-Ulm 
Hydrochloric acid Roth, Karlsruhe 
Hydroquinone Roth, Karlsruhe 
1 kb+ DNA ladder Invitrogen, Groningen 
Isopropanol Roth, Karlsruhe 
LB-agar (Lennox) Roth, Karlsruhe 
Magnesium chloride Roth, Karlsruhe 
Manganese chloride Fluka, Neu-Ulm 
Methanol Merck, Darmstadt 
[S35] L-Methionine Hartmann Analytic, Braunschweig 
Mono-potassium phosphate Roth, Karlsruhe 
Milk powder Serva, Heidelberg 
NNN´N-tetra methylene ethylene diamine  
(TEMED) Fluka, Neu-Ulm 
Nutrient-broth Roth, Karlsruhe 
Pepton Roth, Karlsruhe 
Phenol/chloroform/isoamyl alcohol (25/24/1) Roth, Karlsruhe 
p-coumaric acid Sigma, Taufkirchen 
Ponceau S  Serva, Heidelberg 
Potassium acetate Applichem, Darmstadt 
Potassium bromide Applichem, Darmstadt 
Potassium chloride Merck, Darmstadt 
RostisolV®HPLC Gradient Grade Water Roth, Karlsruhe 
Rotiphorese®Gel 30 Roth, Karlsruhe 
Saponin Roth, Karlsruhe 
SDS-PAGE standard high range Bio-Rad, München 
SDS-PAGE standard low range Bio-Rad, München 
Sodium carbonate Roth, Karlsruhe 
Sodium chloride Roth, Karlsruhe 
Sodium dodecyl-phosphate Roth, Karlsruhe 
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Sodium hydroxide (NaOH) Merck, Darmstadt 
Sodium sulphite Roth, Karlsruhe 
Sorbitol Roth, Karlsruhe 
Sucrose Roth, Karlsruhe 
Trichloroacetic acid Roth, Karlsruhe 
Tris Applichem, Darmstadt 
Yeast extract Roth, Karlsruhe 
 
2.1.3. Antibodies and working concentration 
 
Mouse anti-GFP Roche Diagnostics, Mannheim 
Rabbit anti-mouse, Horse Radish Peroxidase (HRP) DAKO, Glostrup, dilution1:1000 
Rabbit anti-mouse, Alkaline Phosphatase (AP) DAKO Glostrup, dilution1:2000 
Goat anti-rabbit, AP  DAKO Glostrup, dilution1:2000 
Goat anti-rabbit, HRP DAKO Glostrup, dilution1:2000 
Rabbit anti-SERP (Ansorge et al., 1996) 
Rabbit anti-PV1 (Nyalwidhe and Lingelbach, 2006) 
Goat anti-GST GE Healthcare, 1:2000 
 
2.1.4. Enzymes 
 
Restriction Enzymes (RE) 
All REs were from New England Biolabs (NEB): AvrII, BamHI, BglII, EcoRI, KpnI, 
NheI, NotI, PvuII, SpeI, XbaI, XhoI, XmaI.       
        
Other enzymes 
DNase I Applichem, Darmstadt 
RNase Roth, Karlsruhe 
Klenow fragment, DNA polymerase I NEB 
KOD polymerase Novagen, Darmstadt 
Phusion high-fidelity polymerase Finnzymes, Espoo Finnland 
Taq polymerase NEB 
Superscript III reverse transcriptase Invitrogen, Groningen 
T4-DNA-Ligase Invitrogen, Groningen 
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2.1.5. Molecular biological kits and reagents 
 
Eppendorf gel extraction kit Eppendorf, Hamburg 
Seqlab miniprep kit Seqlab, Göttingen 
QIAEX II gel extraction kit Qiagen, Hilden 
QIAGEN plasmid maxi kit Qiagen, Hilden 
QIAprep spin miniprep kit Qiagen, Hilden 
TRIzol reagent Invitrogen, Karlsruhe 
 
2.1.6. Cell culture materials 
 
Albumax Invitrogen, Karlsruhe 
Blasticidin S InvivoGen, San Diego, USA 
Ganciclovir InvivoGen, San Diego, USA 
Gelafundin B. Braun AG, Melsungen 
Gentamycin PAA, Pasching, Austria 
Giemsa Merck, Darmstadt 
Human erythrocyte concentrate (A/rh+) Uni-clinical centre Marburg 
Human plasma (A/rh+) Uni-clinical centre Marburg 
Hypoxanthine PAA, Pasching, Austria 
RPMI 1640 Gibco, Karlsruhe 
RPMI 1640 PAA, Pasching, Austria 
WR99210 Jacobus Pharmaceuticals 
 
2.1.7. Cells and organisms 
 
Strain genotype reference 
E. coli DH5α supE44 ∆lacU169 (Φ80 
lacZ∆M15) hsdR17 recA1 
gyrA96 thi-1 relA1 
Hanahan 1983; Bethesda 
Research Laboratories 1986 
E. coli PMC103 mcrA ∆(mcrBC-hsdRMS-
mrr)102 recD sbcC 
Doherty, Lindeman et. al., 
1993 
E. coli BL21-CodonPlus-RIL E. coli B F– ompT hsdS(rB– 
mB–) dcm+ Tetr gal endA 
Hte [argU ileY leuW Camr] 
Stratagene 
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P. falciparum 3D7 isolated in the Netherlands The Walter and Eliza 
Institute of Medical 
Research, Melbourne, 
Australia 
Transfected P. falciparum various transfection This study 
 
2.1.8. Media and solutions 
 
2.1.8.1. Solutions for protein-based experiments 
 
Acrylamide solution 
30% (w/v) Acrylamide 
0.8% (w/v) Bisacrylamide 
 
Ammonium peroxo-sulphate (APS) 
10% APS in ddH2O 
 
Alkaline phosphatase (AP) buffer 
100 mM Tris-HCl, pH 9.5 
100 mM NaCl 
5 mM MgCl2 
 
AP developing solution 
66 µl NBT(nitro blue tetrazolium) stock solution 
33 µl BCIP(5-bromo-4-chloro-3-indolyphosphate) stock solution 
 
BCIP stock solution 
5% BCIP in Dimethylformamide 
 
Blocking solution 
Stored at -20°C 
5% milk powder in PBS, pH 7.4 
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Colloidal coomassie staining solution 
0, 08% coomassie brilliant blue G250 (CBB G250) 
1, 6% ortho-phosphoricacid 
8% ammoniumsulfate 
20% methanol 
 
Electrophoresis buffer 
0.124 M Tris 
0.96 M Glycin 
0.05 % SDS 
 
Enhanced chemiluminescence solution (ECL) 
50 mM luminol in DMSO 
0.8 mM p-coumaric acid in DMSO 
200 mM Tris/HCl, pH 8.8 
0.01% H2O2 
 
Glycin buffer 
100 mM glycin in PBS, pH 7.6 
 
NBT stock solution 
5% NBT in 70% dimethylformamide 
 
Phosphate buffered saline, pH 7.4 (PBS) 
140 mM NaCl 
2.7 mM KCl 
1.5 mM KH2PO4 
8.1 mM Na2HPO4 
 
Ponceau red staining solution 
0.2% ponceau S 
3% trichloroacetic acid 
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Protease inhibitor cocktail stock solution 
200 µg/ml of each of the inhibitors antipain, chymostatin, aprotonine, pepstatin, 
trypsin, leupeptin, elastinal and Na-EDTA in PBS. Working solution 1:200 dilution 
 
2 X SDS-PAGE: sample buffer (reducing), stored at 4°C 
100 mM Tris/HCl, pH 6.8 
5 mM EDTA 
20% glycerol  
4% SDS 
0.2% bromophenol blue 
100 mM DTT 
 
4x Separating gel buffer 
1.49 M Tris/HCl , pH 8.8 
0.4% SDS 
 
4x Stacking gel buffer 
500 mM Tris/HCl, pH 6.8 
0.4% SDS 
 
Western blot transfer buffer 
48 mM Tris/HCl, pH 9.5 
39 mM glycine 
0.0375% SDS 
20% methanol 
2.1.8.2. Solutions for DNA-based experiments 
 
Agarose  
0.8 to 1.5% agarose dissolved in 1x TAE 
 
Buffer A for DNA extraction 
50 mM NaOAC, pH 5.2 
100 mM NaCl 
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1 mM EDTA 
Cresol red loading buffer pH 8,8 
36% sucrose  
0.1 g cresol red 
 
6x DNA loading buffer  
1% bromophenol blue 
30% glycerol 
50 mM Tris/HCl, pH 8.0 
5 mM EDTA 
 
1 kb+ DNA ladder 
1 volume 1kb+ DNA ladder 
19 volumes 6x DNA loading buffer 
 
DNA purification solutions 
Merlin I 
50 mM Tris/HCl, pH 7.5 
10 mM EDTA 
100 µg/ml RNase 
 
Merlin II 
0,2 M NaOH 
1% SDS 
 
Merlin III 
1 M potassium acetate (KOAC) 
35.7 ml glacial acetic acid 
 
Merlin IV 
66.84 g guanidine hydrochloride in 33.3 ml Merlin III 
Stir, gently heat 5 to 10 min 
pH adjusted to 5.5 with NaOH 
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Merlin V 
200 mM NaCl 
20 mM Tris/HCl pH 7.5 
5 mM EDTA 
50% EtOH 
 
PFGE lysis buffer 
0.5 M EDTA 
10mM Tris/HCl, pH 8.0 
1% sarkosyl 
2 mg/ml proteinase K (proteinase K added fresh just prior to use) 
 
3M sodium acetate (NaOAc) pH 5.2 
 
Southern blotting hybridisation buffer 
Depurination 
0.2 N HCl: 17 ml concentrated HCl in 1 liter dH2O 
 
Denaturation 
1.5 M NaCl 
0.5 M NaOH 
For 1 liter solution 
87.6 g NaCl 
100 ml 5M NaOH or 50 ml of 10M NaOH 
Store at RT up to 3 months 
 
Neutralisation 
1 M Tris pH 7.4 
1.5 M NaCl 
For 1 liter solution 
87.6 g NaCl 
122.1 g Tris base 
pH to 7.4  
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20X SSC 
3M NaCl 
0.3M sodium citrate 
pH 7.0 
 
10X SSC for transfer 
6X SSC for fixation 
 
Hybridisation/Pre-hybridisation buffer 
6X SSC 
5X Denhardt’s solution 
0.5 % SDS 
50 % formamide 
Filter through 0.45µm membrane 
Add freshly 100 µg/ml salmon sperm DNA (SIGMA, DNA sodium salt from 
salmon testes, product number D1626, CAS # 9007-49-2) 
 
Washing solutions 
Wash 1   2X SSC, 0.1% SDS 
Wash 2 0.1X SSC, 0.1 % SDS 
 
50x TAE 
2 M Tris 
2 M acetic acid 
50 mM EDTA 
 
TE 
10 mM Tris 
1 mM EDTA 
pH 7.4 to 8.0 depending on the purpose  
2.1.8.3. Bacteriological media 
 
LB (Luria-Bertani) agar 
35 g/l LB-agar 
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Superbroth, pH 7.0 
35 g/l pepton 
20 g/l yeast extract 
5 g/l NaCl 
SOC-medium 
20 g/l peptone 
5 g/l yeast extract 
10 mM NaCl 
2.5 mM KCl 
autoclaved 
20 mM MgCl2  
20 mM glucose  
Media were sterilised by autoclaving and allowed to cool to 50°C. Appropriate 
antibiotics were then added to a final concentration of 50 µg/ml. 
Antibiotics 
 Stock  working concentration 
Ampicillin (sodium salt) 50 mg/ml  50 µg/ml 
Carbenicillin 50 mg/ml  50 µg/ml 
Chloramphenicol 34 mg/ml  34 µg/ml 
2.1.8.4. Media and solutions for parasite culture and transfection 
 
Antibiotics for selectable markers 
 
WR99210  
a) 20 mM WR99210 stock solution  
8.6 mg WR99210 in 1 ml DMSO, stored long term at –70°C 
b) WR99210 working solution 
Dilute 1/1000 in RPMI-Hepes (= 20 µM). Filter sterilise, store at –70°C or stable for 1 
month at 4oC.  
Recommended working concentration: 5 nM (3 µl of working solution in 12 ml 
culture medium).   
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Blasticidin S hydrochloride 
Stock solution from supplier: 10 mg/ml, stored at -20oC. 
Working concentration 4 µg/ml 
 
Ganciclovir 
From the manufacture’s instruction (Invivogen), ganciclovir is only soluble at pH ≥ 
12. 
Stock solution at 20 mM 
51 mg ganciclovir in about 8 ml water, adjust to pH 12 with 1 M NaOH, 
complete dissolve Ganciclovir. 
Lower pH to 10.7 ~ 11 with HCl. 
Fill up with water to 10 ml solution.  
Filter sterilise, aliquot and store at –70°C or stable up to 1 month at 4oC.  
Working concentration: 20 µM (dilute 1/1000 of stock solution into culture 
medium).  
Cytomix stock buffers 
Cytomix was adapted from Van den Hoff (van den Hoff et al., 1992). 
 
a) 10 M KOH 
b) 250 mM Hepes/20 mM EGTA 
5.96 g Hepes (free acid) 
0.76 g EGTA 
To 80 ml with ddH2O 
pH to 7.6 with 10 mM KOH (~ 1,4 ml) 
to 100 ml with ddH2O 
c)  10ml 1 M phosphate buffer pH 7.6 
8.66 ml 1M K2HPO4  
1.34 ml 1 M KH2PO4 
Cytomix 100 ml, Stored at 4°C 
6 ml 2 M KCl 
7.5 µl 2M CaCl2 
1 ml 1 M K2HPO4/KH2PO4 
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10 ml of 250 mM Hepes/20 mM EGTA pH 7.6 
500 µl 1M MgCl2 
To 90 ml with ddH2O 
sterilised filter 
Freezing solution 
28% glycerol 
3% d-sorbitol 
0.65% NaCl 
RPS medium 
500ml RPMI 1640 medium (PAA or Gibco) 
Supplement with: 
50ml of heat-inactivated human plasma or 50ml of 5% albumax  
20 µg/ml gentamycin 
200 µM hypoxanthine 
 
5% Sorbitol 
Dissolve 5 g sorbitol in 100 ml water, filter sterilise and store at 4oC.  
 
Thawing solutions 
Sterile 12% NaCl 
Sterile 1.6% NaCl 
Sterile 0.9% NaCl + 0.2% glucose 
Malaria culture medium (RPS) 
 
2.1.9. Plasmids 
 
Table 1.  List of plasmids used in this study 
 
Plasmid Resistance Features Reference 
pARL2 WR99210 
Ampicillin 
Basic vector (Przyborski et al., 
2005) 
pARL2-GFP WR99210 
Ampicillin 
GFP expression,  
hDHFR cassette  
(Przyborski et al., 
2005) 
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pARL-BSD-GFP Blasticidin S 
Ampicillin 
hDHFR was removed, replaced by bsd 
cassette 
GFP expression 
Przyborski,  
(personal 
communication) 
pHTK WR99210 
Ampicillin 
Basic vector 
Ganciclovir sensitive 
For double-crossover recombination 
(Duraisingh MT, 
2002)  
pHTK-∆PV1-3 WR99210 
Ampicillin 
Ganciclovir sensitive 
Containing 3’-flank region of 
PF11_0302 
 
pHTK-∆PV1 WR99210 
Ampicillin 
Knock-out construct 
Ganciclovir sensitive 
Containing 2 flank regions of 
PF11_0302 
This study 
pARL-DHFR-PV1g WR99210 
Ampicillin 
PV1-GFP fusion 
 
This study 
pARL-∆PV1g WR99210 
Ampicillin 
Knock-in construct 
Truncated PV1 fused with GFP is non-
expressed in episomal form. 
This study 
pARL-mutPV1 WR99210 
Ampicillin 
Knock-in construct 
Mutated PV1 at very C-terminal end 
This study 
pARL-BSD-PV1g BSD 
Ampicillin 
For double transfection 
PV1-GFP fusion  
This study 
pGem-T-Easy  Subcloning vector Promega, Madison 
USA 
pGEX-5x-3 Ampicillin Recombinant protein expression 
GST tag 
GE Healthcare Life 
Sciences 
pGEX-PV1 Ampicillin GST-PV1 fusion protein This study 
 
2.1.10. Synthetic oligonucleotides 
 
All oligonucleotides were synthesised from MWG-Biotech AG.  
 
Table 2.   List of PCR primers used in this study 
 
Order  Primer name Sequence 5´ 3´ 
 Knock-out primers 
1 PV1-ko5F CGGACTAGTGTGATTAAGAAAAAGAATTAAAAT 
2 PV1-ko5R CGTAGATCTCTATTAGTTTTGATTCTTATTATTGG 
3 PV1-ko3F GACGAATTCCGATCTCTGGAATCGGTAATGTTG 
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4 PV1-ko3R GCGCCATGGGTTTATGTAAATATATACATATAG 
 Integration primers (for integration PCR) 
5 PV1-ig-5F CAGCATTTGAATATTAAATTAAATC 
6 PV1-ig-5F2 GCATCGTAAAATTATAGATATTTCTATG 
7 PV1-ig-3R TTTGAACATGGTCATATGTACTC 
8 PV1-internalF ACAAAGATCAACTTATGGACTTACC 
9 PV1-internalR AAGACATTACCTGATGAAGCATTAC 
10 DHFR-ig5R TTCTTGCCGATGCCCATGTTCTG 
11 DHFR-pm-5R2 TTTATCATGCACATTGGAATAATAC 
12 DHFR-ig3F AAATATAAACTTCTGCCAGAATACCC 
 Primer specific for vectors and Southern blot probes 
13 DHFR probeF AATTAGCAAATAAAGTAGAC 
14 DHFR probeR TTGTAATTTCTGTGTTTATG 
15 pHTK-5F GTATATATATATATATATATATATAGGTATAG 
16 pHTK-5R GGTTAACAAAGAAGAAGCTCAGAGATTGCATG 
17 pHTK-3F AATTCATGTTTTGTAATTTATGGGATAGCG 
18 pHTK-3R GGCTTAACTATGCGGCATCAGAGCAGATTG 
19 pHTK-backboneF TAGACAGATCGCTGAGATAGG 
20 pHTK-backboneR TTGATCCGGCAAACAAACC 
21 TK gene1 GGCCCGAAACAGGGTAAATAACG 
22 TK gene2 CTTCCGAGACAATCGCGAACATC 
23 pARL-F CGTTAATAATAAATACACGCAG 
24 pARL2-Not70-F GCGGATAACAATTTCACACAGG 
25 pARL-R CAGTTATAAATACAATCAATTGG 
26 DHPS-F GGTGGAGAATCCTCTGCTCC 
27 DHPS-R CCAATTGTGTGATTTGTCCAC 
 Knock-in primers/ GFP fusion 
28 PV1-XhoF GGCTCGAGATGATTAAAATAATATTAGCTAGC 
29 PV1-AvrR GGCCTAGGGCTCGATATTGGTGTGTTTTGATC 
30 dPV1-NotF ATGCGGCCGCACAACCAGTAACGGATTTACATG 
31 dPV1-XhoR ATCTCGAGTTAACTCGATATTGGTGTGTTCTGGTC 
 Other primers 
32 PF11_0303F TTTACAGCTACGGAAATTATATC 
33 PF11_0303R CTGTAATGTCTACCTAAATATCTATC 
34 GFP-AvrF TACCCTAGGATGAGTAAAGGAGAAGAAC 
35 GFP-KpnR GGCGGTACCTTTGTATAGTTCATCC 
 Recombinant protein expression primers 
36 PV1-GST-BamF CAGGATCCACAATGTGGTGGCCCCTAAGAG 
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37 PV1-GST-XhoR CAGCTCGAGTTAGCTCGATATTGGTGTGTTTTG 
 
2.2. Methods 
2.2.1 Bioinformatics methods 
For in silico analysis of proteins and nucleic acids the following programs were used: 
Blast http://ncbi.nlm.nih.gov/cgi-bin/BLAST  
ClustalW http://www.ebi.ac.uk/clustalw/ (Larkin et al., 2007) 
MyHITs http://myhits.isb-sib.ch/cgi-bin/motif_scan (Hulo et al., 2008) 
MnM http://mnm.engr.uconn.edu/MNM/SMSSearchServlet(Rajasekaran et 
al., 2009) 
OPI http://chemlims.com/OPI/MServlet.ChemInfo  (Zhou et al., 2005) 
PFP http://dragon.bio.purdue.edu/pfp/ (Hawkins et al., 2006) 
ScanSite http://scansite.mit.edu/motifscan_id.phtml (Obenauer et al., 2003) 
SignalP http://www.cbs.dtu.dk/services/SignalP/ (Bendtsen et al., 2004) 
SMART http://smart.embl-heidelberg.de/ (Schultz et al., 1998) 
Nucleic acid and protein sequences were downloaded from PlasmoDB 
(www.plasmodb.org) and ApiDB (www.apidb.org) (Aurrecoechea et al., 2009). 
Primer designs and vector constructs were in silico confirmed in Clone Manager 7 
(Sci Ed Central). Protein sequence alignment was followed ClustawW (Larkin et al., 
2007) with parameters of Gonnet series, the gap opening 10, gap extension 0.2.  
2.2.2 Transfection of plasmid constructs 
Plasmid constructs for transfection were cloned using the standard cloning strategy 
(Sambrook and Russell, 2001) into E. coli strain strain PMC103. For difficult 
constructs as pHTK-derived vectors, carbenicillin was used for selection of positive 
clones. A large number of colonies were screen by colony PCR. Plasmids from 
positive clones were confirmed by restricted digestion and automated sequencing.  
 
2.2.2.1 pHTK-∆PV1  
Two DNA segments of approximately 1 kb from the PfPV1 encoding gene 
(PF11_0302) were amplified from 3D7 genomic DNA and introduced into the 
flanking regions of the human DHFR (hDHFR) cassette to mediate the integration of 
the plasmid into the parasite genome (Fig. 2.1). Specifically, the 805 bp of 3-flank 
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segment of the PF11_0302 was amplified by the primers PV1-ko3F 5’- 
GACGAATTCCGATCTCTGGAATCGGTAATGTTG and PV1-ko3R 5’- 
GCGCCATGGGTTTATGTAAATATATACATATAG. The amplified product 
encompasses 94 nucleotides of the encoding sequence as well as 711 nucleotides of 
un-translated region downstream of the natural stop codon. The DNA segment was 
inserted into EcoRI/NcoI digested pHTK vector to generate the pHTK∆PV1-3 
plasmid (restriction sites were typed in italic in the oligonucleotide sequences). The 
pair of primers PV1-ko5F 5’-CGGACTAGTGTGATTAAGAAAAAGAATTAAAAT-
3’ and PV1-ko5R 5’- CGTAGATCTCTATTAGTTTTGATTCTTATTATTGG-3’ 
amplified the 5-flank segment of the PF11_0302 gene. The underlined nucleotides in 
the PV1-ko5R primer are encoding two artificial stop codons. In case the single- 
crossover occurs it helps to prevent the expression of the full length PfPV1. The 
product of 844 bp includes 352 nucleotides of the 5' untranslated region, upstream of 
the PV1 start codon as well as the codons representing the first 164 amino acids of the 
translated proteins. The fragment was then inserted into SpeI/BglII – digested 
pHTK∆PV1-3 vector to create the pHTK∆PV1 construct. Note that the final 
pHTK∆PV1 vector still retains the 5’ to 3’ direction of targeting sequence in respect 
of the drug resistance cassette.   
 
2.2.2.2 pARL-DHFR-PV1g 
This vector express PfPV1 protein fused with GFP, under the selection of hDHFR 
selectable marker. Full length encoding PfPV1 sequence without stop codon was 
amplified by RT-PCR, using the primer PV1-XhoF 5’-
GGCTCGAGATGATTAAAATAATATTAGCTAGC and PV1-AvrR 5’-
GGCCTAGGGCTCGATATTGGTGTGTTTTGATC. The amplified DNA fragment 
was ligated to XhoI/AvrII-restricted pARL2-GFP (Przyborski et al., 2005) to create 
pARL-DHFR-PV1g plasmid.  
 
2.2.2.3 pARL-BSD-PV1g 
The sequence encoding the PV1-GFP fusion protein in vector pARL-DHFR-PV1g 
was placed between XhoI and KpnI restriction site. The DNA frgament was cleaved 
and inserted into XhoI/KpnI-restricted pARL-BSD plasmid (Przyborski, personal 
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communication), thus generating the pARL.BSD-PV1g plasmid which also expresses 
PV1-GFP fusion protein but resistant to BSD in stead of WR99210.  
 
2.2.2.4 pARL-∆PV1g 
The basic vector for all pARL-derivative constructs was from pARL-1a (Crabb et al., 
2004). The vector containes the PfCRT promoter to drive the expression of the 
transgene. To create a knock-in parasite line, a truncated version of PfPV1 was 
generated so that the transgene could only be expressed upon integration into the PV1 
locus. The pARL-DHFR-PV1g was digested by NotI/NheI to remove the region of the 
CRT promoter and the first 19 nucleotides of the PfPV1 gene. Sticky ends of linear 
plasmids were filled in by Klenow activity of DNA polymerase I (NEB). Plasmid was 
circularised by T4 DNA ligase, creating the pARL-∆PV1g construct. Sucessfull 
removal of the promoter region was assured by automated sequencing.  
 
2.2.2.5 pARL-mutPV1 
A truncated PV1 encoding fragment was created by primers dPV1-NotF 5’- 
ATGCGGCCGCACAACCAGTAACGGATTTACATG and dPV1-XhoR 5’- 
ATCTCGAGTTAaCTCGATATTGGTGTGTTcTGgTC. The italic nucleotides are 
restriction sites of NotI and XhoI, respectively. The underlined nucleotides represent 
the original stop codon. Bold, small letters are substituted nucleotides in silent 
mutations which result in codons for the same amino acids. Forward oligonucleotides 
were primed at nucleotide 205th of the PV1 encoding sequence, relevant to Thr69 
residue of PV1 protein. The 1100 bp DNA product was digested and consequently 
ligated to NotI/XhoI-restricted pARL2 to create pARL-mutPV1 construct.  
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Figure 2.1: Vector maps for P. falciparum transfection plasmids  
In all plasmids but pARL-BSD-PV1g, the hDHFR cassette is comprised of ~ 1kb of 
calmodulin (CAM) 5’- untranslated region (UTR), 0.56 kb hDHFR gene, and 0.6 kb hrp2 3’-
UTR. In pARL-BSD-PV1g, the hDHFR gene was replaced by the BSD gene. pHTK is a 
double-crossover plasmid used for gene disruption (Duraisingh MT, 2002). The 5’ and 3’ 
target  sequences need to be cloned into the multicloning sites (MSCI and MSCII), 
respectively, in the same direction of the hDHFR cassette, as shown by the arrows. From the 
5’ to 3’ the MSCI are MluI, SacII, SpeI, BglII, HincII, HpaI, and within the MSCII are 
EcoRI, ClaI, NcoI, AvrII, BbeI, KasI, NarI, and SfoI. The expression of TK gene is 
controlled by the HSP 86 5’-UTR and P. berghei 3′ termination region of DHFR-TS gene. 
Note that the expression cassette is head-to-head orientatation against the hDHFR cassette. 
Two flanking regions of PV1 encoding sequence was depicted in the two construct 
pHTK∆PV1-3 and pHTK∆PV1, respectively. The black down-pointing triangle (▼ ) in the 
5’-flanking fragment represents the premature stop codon. pARL2 vector (Duraisingh MT, 
2002; Przyborski et al., 2005) is a basic vector used mainly for expression of GFP-tagged 
proteins. It uses a tail-to-head orientation of the epxression cassettes to avoid the 
bidirectional influence of the CAM promoter on the expression of the gene of interest. The 
GFP fusion proteins are controlled by the CRT promoter and the Pb 3’-UTR as shown in 
pARL2-GFP, pARL-DHFR-PV1g and pARL-BSD-PV1g vectors.  In pARL-∆PV1g and 
pARL-mutPV1, the CRT promoter was removed so that the sequences of interest are only 
expressed under the endogenous promoter upon the integration into the targeting locus. The 
asterisk (*) in the truncated ∆PV1 region indicates the modified nucleotides at the 3’-end 
sequence. Restriction sites used in cloning include NotI (N), XhoI (X), AvrII (A), KpnI (K), 
XmaI (Xm), NheI (Nh), BamHI (B), HindIII (H), EcoRI (E), NcoI (Nco), SpeI (Spe) and 
BglII (Bg). 
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2.2.3 Parasite 
2.2.3.1 Parasite culture 
P. falciparum parasites (strain 3D7 or transfected strains) were cultivated in RPS 
following the standard procedure (Trager and Jensen, 1976), with either human A+ or 
0+ erythrocytes, depending on the ensuing experiments. The parasitemia was 
observed regularly by Giemsa-stained smears under microscopy and the infected 
erythrocytes were replaced by fresh human erythrocytes when culture reached a 
maximum of 10% parasitemia at the latest. Media was changed regularly and parasite 
cultures were gassed with 5% CO2, 5% O2 and 90% N2 and incubate at 37°C. Parasite 
were synchronised by 5 % sorbitol at ring stage (Lambros and Vanderberg, 1979). 
Trophozoites-infected erythrocytes were enriched to a parasitemia higher than 90% by 
gelafundin floatation (Pasvol et al., 1978).   
2.2.3.2 Parasite transfection 
Synchronised ring stage parasites with a parasitemia of 5 to 10% were used for 
transfection. To synchronise the culture, parasites were either treated with gelafundin 
one day prior to transfection or with Sorbitol two days prior to transfection. Cell pellet 
from 5 ml of culture (app. 200 µl) in addition of 200 µl fresh blood (0+, donated by 
Jude M. Przyborski or Nina Gehde) were required for each transfection. A large 
amount of plasmid DNA was required for transfection of P. falciparum, at least 50 µg 
of the vector (usually 80 - 100 µg). DNA was precipitated in ethanol and the pellet 
was dried in a laminar flow hood to assure the sterilised condition. After DNA was 
fully dissolved in 30 µl of sterile TE (pH 8.0), 385 µl sterile Cytomix was added.  The 
Cytomix/plasmid sample was mixed with the parasitized erythrocyte pellet and 
transferred to a 0.2 cm Gene Pulser cuvette (BioRad). Electroporation was carried out 
at 0.310 kV and 950 µF (high capacitance). The resulting time constant should have a 
magnitude between 7 and 12 msec. After electroporation the cells were immediately 
transferred to a culture flask containing 12 ml prewarmed RPS and 400 µl fresh blood 
(0+). Four to six hours post transfection drug selection with WR99210 (WR) was 
started. 3 µl of 20 µM WR were added daily the first 5 to 6 days until no more 
parasites were visible. Accordingly the culture was fed twice a week with the same 
concentration of WR (5 nM) and media changes were carried out. Every two days the 
culture was checked for living parasites via Giemsa-stained smears. Fresh RBS was 
added once a week (~100 µl). As soon as parasites were visible (average 21-30 days) 
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three 1 ml aliquots containing predominantly ring stage parasites with a parasitemia of 
at least 2% were resuspended in 1 ml freezing solution and immediately frozen in 
liquid nitrogen.  
For double transfection, parasites already bearing the pHTK∆PV1 episomally were 
co-transfected with pARL-BSD-PV1g following the standard protocol above. The 
double transfected parasites (db-transfected) were put under drug selection of both 5 
nM WR and 4 µg/ml blasticidin (Invivogen). Parasites resistant to both drugs were 
first visible on Giemsa-stained smears after 21 days.  
2.2.3.3 Drug selection of integrated plasmid containing parasites 
For negative selection of pHTK∆PV1-transfected parasites with the purpose of 
double-crossover homologous recombination, 20 µM of ganciclovir was added to the 
WR99210 resistant population. The WR selection continues during ganciclovir 
treatment. Three batches of cell culture were carried out independently in parallel in 
attempt of obtaining the integrant. Parasites mostly died after adding ganciclovir and 
were visible again in Giemsa-stained smears at various times in different cultures (12 
days or 40 days or unable to recover, respectively). The recovered parasites were 
cultured until parasite growth was firmly established.  
 
In another approach to select parasites with the plasmid vector integrated by 
homologous recombination, the pHTK∆PV1-transfected parasites were grown for 3 
weeks without positive drug selection (WR) then reapplied drug pressure and 
continued to culture until parasites reappeared in the Giemsa-stained blood smears. 
The on and off drug cycling could be extended to 3 or more cycles until no parasite 
death was observed after the addition of WR.  
 
For the double transfected parasites, on the background of WR and blasticidin-S 
resistance, 3 cycles of WR selection were applied as describe above. Genomic DNA 
was extracted at each cycle. After the 3rd cycle, two independent populations were 
separated. The db-transfected A population was merely put under WR and blasticidin-
S selection and the db-transfected B population was negatively selected by adding 
ganciclovir as above. The B parasites re-appeared after 10 days in the presence of 3 
different drugs: 5 nM WR, 4 µg/ ml blasticidin-S and 20 µM ganciclovir.  
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All parasites from the attempted homologous recombination studies were in mixed 
population and these cultures were cloned by limiting dilution (Rosario, 1981) before 
further analysed by Southern Blotting to determine if integration into the relevant 
gene had been obtained. 
 
2.2.3.4 Parasite cloning by limiting dilution 
The transfected parasite culture was a mixed population of episomal plasmid and the 
integrated plasmid-containing parasites. Single clones were picked up via limiting 
dilution in a 96-well microtitre plate at a dilution of 0.3 parasites per well (Rosario, 
1981). Briefly, the parasitemia of ring stage cultures were calculated, the number of 
RBC per µl culture was counted using a Neubauer hemocytometer and the number of 
parasites per µl of cell culture suspension was then determined. The dilution of cell 
culture suspension was added to the fresh RPS so that approximately 30 parasites 
were seeded into the 96-well microplate. Fresh medium and 8 µl of RBC per well 
were fed every week. Parasite growth was monitored after 2 to 3 weeks by Giemsa-
stained smear. The positive clones were eventually transferred to 5ml and later to 
usual culture volume. Considering the time from the start, 4 to 5 weeks were required 
to establish a firmly culture for a single parasite clone.  
2.2.4 Monitoring transfectants: genetic analysis 
 
2.2.4.1 PCR analysis 
For the detection of the expected homologous integration event, a quick screening 
method was first performed using the combination of various primers (see the primer 
map (Figure 3.5 in Result section). The same basic PCR master mix comprised of Taq 
polymerase, 20 pmol of each primer in diverse combination, 200 µM of each dNTP in 
suitable PCR buffer was used for different templates. Typically, 1 µl of genomic 
DNA was used for a 50 µl-volume PCR reaction. The basic PCR program run through 
35 cycles of 95oC/30 sec, 50oC/30 sec and 68oC/2 min 30 sec. Optimised conditions 
were also tested, using different polymerases, increasing concentration of PCR 
components such as Mg2+, primers,  DNA template or  changing time requiring for 
each step.   
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2.2.4.2 Southern blot analysis  
Various DNAs were double digested with XbaI and EcoRI or NheI and PvuII then 
proceeded for Southern blotting (SB) hybridisation with different probes, using the 
standard SB protocol (Sambrook and Russell, 2001; Southern, 1975). Generally, 10 
µg of genomic DNA and 10 units of each RE (New England Biolab) were used in the 
double digestion in 100 µl total volume, incubated overnight or 16 hours at 37oC. 
Frequently two probes were required for an identical blot, hence samples were 
arranged in favor of duplicate lanes in the same gel. The 10 µg digested genomic 
DNAs were split into 2 distant lanes on a 0.8% agarose gel at 5 µg per slot. If the 
number of samples exceeded the available wells, a second gel was prepared.  
 
Gel electrophoresis was run overnight or 16 hours at 17 Voltages. After staining with 
Ethidium Bromide (EtBr), the stained gel was aligned with a transparent ruler and 
photographed under UV illumination. The gel was then depurinated in 0.125 M HCl 
for 20 min, denatured in denaturation buffer (0.5M NaOH, 1.5 M NaCl) for 30 min, 
neutralised in neutralisation buffer (0.5 M Tris pH 8.0, 1.5 M NaCl) for 30 min, 
changed into the new neutralisation buffer and continued soaking in 15 minutes. 
DNAs on the gel were then blotted onto a pre-wet Hybond-N+ membrane (GE 
Healthcare) in 10X SSC overnight. DNA fixation on the membrane was carried out by 
baking at 80oC for 2 hours. The membrane was wrapped by SaranWrap and stored at 
4°C until needed. 
 
Pre-hybridisation was carried out in a roller bottle at 0.1 ml hybridisation buffer per 1 
cm2 of membrane at 42oC for at least 2 hours. During the pre-hybridisation, the probes 
were labelled with [α-32P]-dATP by HexaLabel Plus kit (Fermentas) following the 
manufacturer’s protocol. The probes were added to the fresh hybridisation buffer at 
10-20 ng/ml or 0.5 – 2 × 106 incorporated counts per ml solution. The membrane was 
hybridised overnight at 42oC with gentle agitation. After the hybridisation, the blot 
was washed 3 times of 20 min/ RT in Washing solution 1 (2X SSC, 0.1% SDS), 
followed by 2 times of 20 min/50oC in Washing solution 2 (0.1X SSC, 0.1% SDS). 
From the last stringency wash, the blot was wrapped in Saran Wrap and exposed to X-
Ray film.  
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If re-probing was required, the blot was re-used by hot SDS stripping protocol (GE 
Healthcare’s instruction). The boiling solution of 0.1% SDS was poured onto the blot 
and allowed to cool. This step was repeated at least 3 times. The removal of the probe 
was checked by exposing the stripped blot to X-Ray film for 1 week. If the signal was 
persistent, the same procedure was repeated.  
 
2.2.4.3 Pulsed field gel analysis (PFGE) 
The PFGE was performed using the CHEF-DR III Variable Angle System (Bio-Rad). 
0.8 % agarose (Certified Megabase Agarose – BioRad) gel was prepared in 0.5X 
TBE. The chromosome blocks (see 2.2.5.4 below) were equilibrated for at least 30 
min in the running buffer at room temperature before they were loaded on the gel. 
After loading, the wells were sealed with 1% (w/v) low melting point agarose and the 
gel was run at the appropriate running conditions (Hinterberg and Scherf, 1994): 0.5 
X TBE/18o C in 2 phases ramping switch 90 – 300 s pulse in 24 hours at 3 V/cm (or 
95 volts) and 300 – 720 sec in 24 hours at 2.5 V/cm (or 85 volts). After the run was 
complete, the gel was stained with ethididum bromide and photographed on a UV 
transluminator. For efficient transfer, the large DNA fragments separated by PFGE 
were nicked by UV irradiation in 5 minutes prior to transfer to hybridization 
membranes. The DNA can then be hybridised using standard Southern blot protocol.  
2.2.5 Preparation of nucleic acid materials 
 
2.2.5.1 Preparation of transfection plasmids 
 
Because the tranfection of foreign DNA into P. falciparum requires a large amount of 
DNA material, the transfection plasmids were prepared in a large volume, using the 
QIAGEN MaxiPrep kit. The volume of the bacterial overnight culture was raised to 
400 ml Superbroth and the plasmids were extracted following the manufacturer’s 
instruction, with a slightly modification of using double volume of resuspension-, 
lysis- and neutralisation buffer. The isolated plasmids were precipitated in 100% 
Ethanol. The DNA pellet was stored in 70% ethanol at -20o until used.  
 
2.2.5.2 Preparation of P. falciparum genomic DNA 
 
For the best yield of genomic DNA, a culture with 6-10% trophozoites was used 
(Crabb et al., 2004). Cell pellet was resuspended in 10 ml cold PBS. After addition of 
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100 µl of 10% Saponin, the tubes were inverted 5 to 6 times and incubated for 10 min 
on ice. Afterwards the cell lysate was centrifuged at 3000 rpm/ 5 min. Saponin lyses 
the erythrocyte membrane and the PVM, hence the pellet contains the intact parasites 
and membraneous particles from RBCM and PVM. The supernatant was discarded 
and the parasite pellet was washed with PBS until no more haemoglobin was visible. 
The washed pellet was either directly further treated or stored at -20°C. 250 µl PBS, 
250 µl 2X buffer A and 100 µl 20% SDS were added, the tubes were inverted and 
incubated for 2 min at room temperature. A double volume of phenol/chloroform was 
added and mixed thoroughly. The mixture was centrifuged at 5000 rpm for 10 min. 
The aqueous phase containing DNA was transferred to a clean tube and extracted 
twice with 1 volume of phenol/chloroform, once with chloroform. The final aqueous 
phase was then precipitated by adding 1/10 volume of 3 M sodium acetate (pH 5.2) 
and 2.5 volumes of 100% ethanol. The precipitated DNA was kept at -20oC for at 
least 1 hour or overnight storage. DNA pellet was washed with 70% ethanol. The 
pellet was resuspended in 100 µl TE (pH 8.0) and stored at 4°C. 
 
2.2.5.3 Preparation of P. falciparum RNA  
 
For isolation of RNA from P. falciparum a saponin-lysis with several washing steps 
was performed as described above. The pellet was resuspended in 37°C Trizol 
(Invitrogen). After a double cycle of freezing/thawing, 200 µl chloroform were added, 
mixed and centrifuged for 15 min at 13000 rpm. The upper phase was transferred to a 
new Eppendorf tube and 1 volume isopropanol was added. The sample was incubated 
for at least 1 h at -80°C, centrifuged 13000 rpm/ 30 min/ 4°C, the supernatant was 
discarded, the pellet was air-dried and resuspended in a selected volume of TE (pH 
7.4 to 7.6) with 1 µl RNase out (Invitrogen). 
 
2.2.5.4 Preparation of P. falciparum chromosome blocks 
 
To resolve chromosomal DNA of P. falciparum by PFGE, chromosomal DNA was 
embedded into agarose plugs. A parasite culture containing 5-7% trophozoites was 
saponin-lysed and the parasites were pelleted by centrifugation. To prepare the blocks, 
the parasite pellet was resuspended in three times the pellet volume of warm (50oC) 
PBS. The same volume of warm (50oC) 2% (w/v) low melting point agarose in PBS 
was added and the mixture was transferred into the plug molds (Bio-Rad) and allowed 
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to set on ice. Once set, the blocks were transferred into PFGE-lysis buffer and 
incubated at 50oC for 48 hours. Chromosome blocks were stored in PFGE-storage 
buffer at 4oC until used.  
2.2.6 Methods on parasite proteins 
2.2.6.1 Fractionation of infected erythrocytes by SLO  
Cell fractionation using SLO (kindly provided by Professor S. Bhakdi) was carried 
out as described previously (Ansorge et al., 1996). The trophozoite-iRBCs were 
enriched by gelafundin floatation. Subsequently 108 iRBCs were incubated in 4 
hemolytic units of SLO. The samples were incubated 6 min at RT, centrifuged at 
4000g/ 5 min to extract the erythrocyte cytosol from the permeabilized host cells. This 
resulted in the release of all haemoglobin and RBC cytosol contents. Following SLO 
lysis, the pellet (named SLO- pellet to distinguish from other pellets below) was 
washed three times in PBS or until visibly clear from haemoglobin. The SLO pellet 
contains intact parasites, the vacuolar content and membranous particles. To separate 
the soluble proteins (SLO-soluble fraction/ SLO-SF) from membranous fractions 
(SLO-MF), the SLO pellet was lysed in 10 mM Tris, 1 mM EDTA and protein 
inhibitor cocktail (PIC, Calbiochem) and subjected to three cycles of 
freezing/thawing. The soluble fraction was collected by centrifugation at 18.000 rpm/ 
30min/ 4oC. Equal equivalents of each fraction were analysed by SDS-PAGE and 
immunoblot analysis.  
2.2.6.2 Labelling the newly synthesised parasite proteins with [35S]L-methionine  
The ring stage iRBCs equivalent to 109 parasites (3D7) were washed twice in 
methionine-free RPMI 1640 medium and cultivated to the next stage in methionine-
free RPS culture medium, with the addition of 100 µCi [35S]L-methionine (Helmby et 
al., 1993). The culture flask was incubated at 37oC as usual for approximately 24 
hours or until late trophozoites (36 - 40 hours) developed. The iRBCs were 
fractionated by SLO as described above (2.2.6.1).  
2.2.6.3 Fluorescence microscopy 
For live-cell imaging gelafundin-enriched parasites stained with Hoechst 33258 
(Invitrogen) were directly applied on a glass slide and imaged immediately at room 
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temperature. Images were acquired using the appropriate filter sets on a Zeiss Axio 
(Carl Zeiss, Jena) observer inverse epifluorescence microscope system.  
2.2.7 Immunoblotting analysis 
 
The immunobloting analysis was performed following the standard protocol 
(Sambrook and Russell, 2001). Briefly, proteins were first separated on 10 % SDS-
PAGE. After SDS-PAGE, the gel and a piece of slightly bigger size of nitrocellulose 
membrane were soaked with transfer buffer (39 mM Glycin, 48 mM Tris, 0.0375% 
SDS, 20% methanol) for 5 min. The transfer sandwich was assembled from anode to 
cathode with 3 pieces of Whatmann 3MM paper soaked with transfer buffer, 
nitrocellulose membrane, separation gel and 3 pieces of Whatmann paper soaked with 
transfer buffer at 1mA/cm2 in one hour. Proteins were stained with Ponceau-S, marker 
bands were marked and the membrane was washed with 1 x PBS until the colouring 
was removed. The membrane was incubated in blocking solution (5% skim milk in 
PBS) for one hour to block unspecific protein binding sites. Subsequently the 
membrane was incubated in the first antibody [rabbit anti-SERP (1:500) (Ansorge et 
al., 1996), mouse anti-GFP (1:1000, Roche), mouse anti-PfHSP70 (1:1000, a gift of 
T. Blisnick), rabbit anti-PV1 (1:500) (Nyalwidhe and Lingelbach, 2006) or goat anti-
GST (1:2000, GE Healthcare)] at 4oC overnight. The next day the membrane was 
washed three times with 1x PBS for 15 min followed by one hour incubation with the 
appropriate secondary antibody, either horseradish peroxidase-conjugated (HRP) or 
alkaline phosphatase-conjugated (AP) anti-mouse, anti-goat or anti-rabbit antibody, 
respectively (DAKO, Santa Cruz, 1:2000). Specific proteins were detected by ECL 
(GE Healthcare) or by AP dectection.  
2.2.8 Expression and purification of recombinant proteins 
2.2.8.1 Constructing the expression vector  
For pGEX-PV1, the DNA sequence corresponding to the PV1 protein without the N-
terminal signal peptide was amplified using the primers PV1-GST-BamF 5’- 
CAGGATCCACAATGTGGTGGCCCCTAAGAG and PV1-GST-XhoR 5’- 
CAGCTCGAGTTAGCTCGATATTGGTGTGTTTTG. Restriction sites are italic 
typeface, stop codon is underlined. The PCR product was digested with the enzymes 
BamHI and XhoI and ligated to the pGEX-5x-3 vector (GE Healthcare) downstream 
Materials and Methods 
  
 58 
of the GST encoding sequence to create the pGEX-PV1 vector. The sequence was 
confirmed by automated sequencing. 
2.2.8.2 Over-expression and solubility test of recombinant proteins in E. coli 
For the expression of GST-PV1 fusion protein, the construct was transformed into E. 
coli BL21-CodonPlus-RIL (Stratagene). P. falciparum has a high codon bias of AGA 
arginine, CUA leucine and AUA isoleucine (Nakamura et al., 2000). The E. coli 
strain used here contains extra copies of the corresponding tRNA genes, allowing a 
high level expression of proteins of interest. This RIL-plasmid confers a 
chloramphenicol resistance. 5 ml overnight culture were seeded into 50 ml LB 
medium with ampicillin and chloramphenicol. Bacteria were grown to OD600 of 0.8 – 
1.0 and the protein expression was induced at 1 mM IPTG in 4 hours at 30oC. Every 
hour the cell pellet from 1 ml culture was harvested and stored at -20oC until needed. 
The cell pellet was resuspended in 50 µl lysis buffer (100 mM NaCl; 25 mM 
Tris/HCl, 1 mM PMSF pH 8.0). Lysozyme was added to 1 mg/ml and the 
resuspension was sonicated 3 x 15 sec. The cell lysate was centrifuged at 13.000 
rpm/5 min/ 4oC and the supernatant was saved as soluble fraction. The insoluble 
fraction was resuspended in 25 µl lysis buffer and 25 µl 2X sample buffer. In each 
step, a sample volume equivalent to 200 µl of culture was analysed by SDS-PAGE.   
2.2.8.3 Purification of GST fusion protein from E. coli  
The  purification of the PV1GST fusion protein was modified from standard protocol 
(Smith and Johnson, 1988) and from the manufacturer’s instruction (GE Healthcare). 
400 ml of bacterial culture were grown to suitable OD. After induction, the volume 
culture was split to 2 x 200 ml and spun down at 6000 rpm/ 15min/ 4oC (GSA Sorvall 
rotor). Cells from 200 ml of culture were subjected to purification. The rest was stored 
at -80oC until needed. Cells were resuspended in 10 ml binding buffer (1 X PBS, 
5mM DTT, 1mM PMSF) and lysed by sonication in 3 minute, 10 sec ON/ 10sec OFF. 
After sonication, Triton X-100 was added to the final concentration of 1% and the cell 
lysate was clarified by centrifugation at 16000 rpm/ 30 min/ 4oC (SS34 Sorvall rotor). 
The supernatant after centrifugation was loaded onto the equilibrated bulk-pack 
column of 200 µl bed volume of Glutathione S-Sepharose 4B (GE Healthcare). The 
unbound proteins were washed from the column 3 times with binding buffer. The 
PV1GST fusion protein was eluted by elution buffer (20 mM Glutathione, 50 mM 
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Tris-HCl pH 8.0, 120 mM NaCl). All samples were analysed by SDS-PAGE. The 
GST protein alone was also expressed from the vector pGEX-5x-3 and purified for 
further use as control. For GST pull-down assay, both PV1GST and GST protein were 
dialysed against 1X PBS for 16 hours at 4oC before added to the pull-down 
experiment.  
2.2.9 GST pull-down assay 
SLO-SF of late trophozoites (36 – 40 hr post invasion) was pre-cleared before the 
assay. Briefly, the lysate of 2×108 parasites was incubated with 50 µl of 50% slurry of 
Gluthione Sepharose 4B and 25 µg of GST [followed (Sambrook and Russell, 2001)] 
for at least 2 hours at 4oC. The mixture was spun down at 13000 rpm/ 2min/ 4oC and 
the pre-cleared cell lysate in the supernatant was transferred to a fresh tube. The in 
vitro protein interaction assay for P. falciparum was adapted from the standard 
protocol (Sambrook and Russell, 2001) and from the previous publications (Bracchi-
Ricard et al., 2005; Murphy et al., 2004). In short, an equimolar amount of PV1GST 
and GST alone was used in the assay. The molecular mass of PV1GST protein was 
calculated by Compute pI/Mw at Expasy (Gasteiger, 2005) and the mass – molar 
quantity was converted by calculation software at 
http://molbiol.edu.ru/eng/scripts/01_04.html. Approximately 200 pmol of protein, 
equal to 15 µg of PV1GST or 5 µg of GST alone were bound to 50 µl Glutathione 
Sepharose beads first, at least 2 hours at 4oC. A control of the Glutathione Sepharose 
4B beads alone was also performed in parallel. Pre-cleared lysate from SLO-SF of 
2×108 parasites (200 µl) was then mixed to the complex and incubated overnight at 
4oC with gentle agitation. After 5 washing steps with TBST (Tris buffer saline and 
Tween 20: 10 mM Tris HCl- pH 8.0, 150 mM NaCl, 0.1% Tween-20), the complex 
was boiled in SDS-PAGE buffer, and centrifuged to remove the beads.  An amount of 
2×108 cells equivalent was loaded in each lane. For a sensitive approach, the protocol 
was applied to the SLO-SF lysate from [35-S]L-methionine labelled parasites and the 
gel was exposed to an X-ray film for 1 week at −80oC or longer. In addition, a normal 
cell lysate was also subjected to the assay, the observed bands on the gel were 
obtained and investigated by mass spectrometry (kindly helped from Dr Omid Azim-
Zadeh and Bsc. Caroline Odenwald). 
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3. Results 
 
3.1. PV1 identification, orthologs and bioinformatics analysis 
 
Data from PlasmoDB (Aurrecoechea et al., 2009) and OrthoMCL database (Chen et 
al., 2006) have shown that PfPV1 orthologs are highly conserved in Plasmodium 
species. However, BLASTP searches against the genomes of other Apicomplexa 
(www.apidb.org) (Aurrecoechea et al., 2009) and the NCBI- BLASTP cannot find 
any similarity in other Apicomplexa nor other genera. The protein shares 26.7% 
identity, 44.4% similarity with PKH_092690 from P. knowlesi, and 24.8% identity, 
41.3% similarity with Pv092070 from P. vivax [by ClustalW2, (Larkin et al., 2007)], 
(Figure 3.1). However, the predictions for PfPV1 lack any information about domain 
structure and function. Domain searches using SMART (Letunic et al., 2009; Schultz 
et al., 1998) only reveal a coiled-coil region from residue 294 to 333 besides a low 
compositional complexity region in the sequence from 157 to 170 
(157DPNNKNQNEDNVDN170). Interestingly, PfPV1 possesses an exclusively 
glutamine-rich region at amino acid residues 302-346 which does not exist in other 
Plasmodium species (Figure 3.1). This glutamine-rich region is also part of the coil-
coil region above, which is defined by Scansite (Obenauer et al., 2003) as a DUF2040 
domain (DUF: domain of unknown function), assigned in residues 315 – 337.  
Globpslot (Linding et al., 2003) predicts an additional globular domain at the N-
terminus, between residues 1-156 (Figure 3.1A) and other intrinsically disorder 
regions [157,167], [212, 228], [263, 270], [371, 392] and [404, 452].  
Various motif scanning sites, MyHits (Hulo et al., 2008), Minimotif Miner - MnM 
(Rajasekaran et al., 2009), Scansite (Obenauer et al., 2003) and PFP (Hawkins et al., 
2006) gave no significant hints to the function of PfPV1. MotifScan MyHits (Hulo et 
al., 2008) barely predicted weak matches for motifs of N-glycosylation, casein kinase 
II (CK2) phosphorylation site, N-myristoylation, protein kinase C (PKC)  
phosphorylation site and the glutamine rich region from 302 – 346 as depicted above. 
The prediction for orthologs from P. vivax and P.knowlesi also resulted in those 
motifs. Giving that the parasite lacks any evidence of N-glycosylation (Gowda and 
Davidson, 1999; von Itzstein et al., 2008), all the prediction of N-glycosylation sites 
on PfPV1 and the orthologs were likely negative results. From the latest update of 
MnM (Rajasekaran et al., 2009) and based on the conserved region of cross species, 
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some motifs were predicted (Table 3). However whether or not they are true 
functional motifs requires experimental studies. Previous attempts to identify post-
translational modifications by mass spectrometry did not discover any modification 
pattern, even though particular attention was paid to myristoylation and 
phosphorylation (Nyalwidhe, unpublished observation). Nevertheless, it remains 
possible that PfPV1 may be post-translationally modified.  
In combination with Ontology Based Pattern Identification - OPI (Zhou et al., 2005), 
PlasmoDB classifies PfPV1 into GO groups: GO:0007154 (cell communication, 
based on biological process); GO:GNF0206 (cytoadherence, Literature Combined 
database) (Aurrecoechea et al., 2009) as well as the groups from literature resources 
of PV localisation, GO:PM16470785 (Nyalwidhe and Lingelbach, 2006) and the 
interaction network by Y2H, GO:PM16267557 (LaCount et al., 2005). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
302 - 346 
294  -  333 
Coiled-coil Gln rich SP Globular domain 
A 
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P.vivax           MKKAALSILLLLLPVYSLNLDNENQ--EPEEINTITGKLQVQNSEHEKILSIINEIFTKK 58 
P.knowlesi        -KKVALSIVLLLLPVYSLSIDNANQ--EPEEIKNITAKLQVQNSEHEKFLSVINEIFTKK 57 
P.falciparum      -IKIILASFLFFFYFSSSIYGNVVAPKSAEAVHTLTAKLDTENKAHQKYIDIINGVFSEN 59 
                    *  *: .*::: . *   .*     ..* ::.:*.**:.:*. *:* :.:** :*::: 
 
P.vivax           EESCKFSFSN-NGFRCAFSRFDVNFNNSSKAVNALFTSENEQVIKDAAEEYKVRLMLELH 117 
P.knowlesi        DDSCKFSFSN-NGFKCAFSKFDVNFNNGSKEMNALFNNANEQIIKDAAEEYKVRLMLELH 116 
P.falciparum      MENFVFSITTSNGFTCSINKLDVIFDNKVTGMQKVFSDENVQYIKEASLEFKNNLLEYMK 119 
                   :.  **::. *** *::.::** *:*  . :: :*.. * * **:*: *:* .*:  :: 
 
P.vivax           NLRPPNTNLKNFKKNFQGICMKFFSELRRKFFHLYRNDESGQDGEGSSRGEITSGDQLTE 177 
P.knowlesi        NLRPPTTNLKNFKKDFQGICMKFFSELRRKFFHLYRNNESNEDGDVNQNDDITNVDQLTE 176 
P.falciparum      GVMPSENDFSNVRKEFQKVCVKYFSELRRKFFQIYRDPNNKNQNEDNVDNHMNIEEISQE 179 
                  .: *. .::.*.:*:** :*:*:*********::**: :. ::.: .  ..:.  :   * 
 
P.vivax           RMESSYDSASTEDGSNAGKDGSQDLSELMEED--------DEHNPDAPNMQQSSYSFSSH 229 
P.knowlesi        RLESTYDSASTEDGSISGKDKKQDLSEVMEDD--------EENNLDVPHVQ-SSYSFSSH 227 
P.falciparum      FFSGFNPFGTMKIRKEQNPDLSQKDSLILNENNNDSLTSADQKNNNMVPMENRSFSYSQQ 239 
                   :..    .: :  .  . * .*. * :::::        :::* :   ::  *:*:*.: 
 
P.vivax           TSKKIMFDG-NNVIEENESSVNDGGDDQSEDLQQGPMTKEKAVSIMLKNTSFTIEGKCTE 288 
P.knowlesi        TSKKIVFDG-NNVIEENESSINDGSDDQNENLEQGPMTKEKALSIFLKNSSFSIEGNITE 286 
P.falciparum      SSHVVSFDGHDEHVEQQEQHSGDNTQEDKDQLMDLPFNKDKVFSTFLKNVTLLIEGNCTE 299 
                  :*: : *** :: :*::*.  .*. :::.::* : *:.*:*..* :*** :: ***: ** 
 
P.vivax           EDE------------------------------------------KKEKPFSVFFNSQLS 306 
P.knowlesi        EDQ------------------------------------------NKEKPFSVFFNSQLS 304 
P.falciparum      AQQQAQEQTQEQTEEQEEEQNEKEIESDKQVQKDGEQKENDVQKKQKANAFTIQFSSSLS 359 
                   ::                                          :* :.*:: *.*.** 
 
P.vivax           RNHFSTVCNSNGKNFLRKADGGSPFPVEPLNPDDLNRMMADMLKFFESQSDGNRMLLPFL 366 
P.knowlesi        RNHISTVCNANGKNMLRGSGSNNPFPMEPLNPDDLNKMMNDMVKFFESQNDGNGMMLPFL 364 
P.falciparum      RKHISTTCNASSGNVFLRKGNK---PFEHFNSPNFENMMKGVFGIIQNPFENGQPTFPFF 416 
                  *:*:**.**:.. *.:   ..    *.* :*. :::.** .:. :::.  :..   :**: 
 
P.vivax           GKMNFMDALGSLGLPPGLDLESMFNDFLQGNG-TPCCRGARPTIGGPSNKQDPPSADDSD 425 
P.knowlesi        NRMNFNEALGNLGLPSGLDIESMFNDFLQKSGSNPCCRGARPQIDQPPKKEDPPTTDDSD 424 
P.falciparum      KNINSISGIGNVDIP-----KNFMNDFLNNGN-----------------DQNTPISS--- 451 
                   .:*  ..:*.:.:*     :.::****: ..                 .::.* :.    
 
P.vivax           EQH 428 
P.knowlesi        NQQ 427 
P.falciparum      --- 
                      
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Structure, feature and conservation of PfPV1. (A) Schematic 
representation of full-length PfPV1 showing the signal peptide (SP) at the N-terminus 
(residues 1-21, red box), a predicted globular domain (residues 1 – 156, light yellow 
box), a coiled-coil region (residues 294 – 333, green can) and a glutamine-rich region 
(residues 302-346,  open rectangle). Features were predicted by SMART (Letunic et 
al., 2009; Schultz et al., 1998) and Globpslot (Linding et al., 2003). The surface 
accessibility map was plotted from Scansite (Obenauer et al., 2003). (B) Sequence 
similarity by ClustalW2 (Larkin et al., 2007) between proteins encoded by P. vivax 
Pv092070, P. knowlesi PKH_092690 and P. falciparum PF11_0302, respectively. 
Sequences were retrieved from PlasmoDB. Genome sequencing from other Plasmodia 
are not completed therefore the alignment of the whole group is not available. Identical 
(*), highly similar (:), similar (.) residues and gaps (---) are indicated. The conserved 
residues are shown in bold type. The predicted N-terminal signal peptides are 
underlined.  
 
B 
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Table 3. Mini motifs predicted in PfPV1  
Known motif Position(s) 
in PfPV1 
Conserved in other Plasmodium 
Homologous sequences 
Function 
[S/T]Q 202 P.v      ---KDGSQDLSELMEE---  
P.k      ---KDKKQDLSEVMED---  
P.f      ---PDLSQKDSLILNE---  
This consensus motif is 
phosphorylated by 
ATM; phosphorylation 
Thr; no modification 
required 
PxxxD 276 P.v      ---LQQGPMTKEKAVSI--- 
P.k      ---LEQGPMTKEKALSI--- 
P.f      ---LMDLPFNKDKVFST---                   
This consensus motif 
in peptide binds 
platelet fibrinogen 
receptor; no 
modification required 
SxxxS 202,234 This consensus motif 
in beta-catenin is 
phosphorylated by an 
unknown target; 
phosphorylation ; no 
modification required 
[S/T]xxx[S/T] 202, 234 
P.v  GSQDLSELMEED--------DEHNPDAPNMQQSSYSFSSH  
P.k  KKQDLSEVMEDD--------EENNLDVPHVQ-SSYSFSSH  
P.f  LSQKDSLILNENNNDSLTSADQKNNNMVPMENRSFSYSQ  
              
 
This consensus motif 
in glycogen synthase is 
phosphorylated by 
GSK3 beta; 
phosphorylates N-
terminal Ser/Thr; C-
terminal Ser/Thr must 
first be phosphorylated 
Sxx[S/T] 238, 357 
 
 P.v     SSYSFSSHTSKKIMFDG 
 P.k     SSYSFSSHTSKKIVFDG 
238 P.f     RSFSYSQQSSHVVSFDG 
 
 P.v     KKEKPFSVFFNSQLSRNHFST 
 P.k     NKEKPFSVFFNSQLSRNHIST 
357 P.f     QKANAFTIQFSSSLSRKHIST 
         
 
This consensus motif is 
phosphorylated by 
casein Kinase I; 
phosphorylation 
Ser/Thr; first Ser must 
be phosphorylated 
[FILVW]xxx[FI
LV]xxxx[FILV
W] 
 
 
 
 
 
 
 
 
74, 283, 
355 
This consensus motif 
binds the #1 
calmodulin domain of 
calmodulin; no 
modification required 
Type 1-5-10  
 
 
[FILVW]xxx[F
AILVW]xx[FAI
LVW]xxxxx[FI
LVW] 
 
 
416 
CaM binding motif 1-
5-8-14, the relevant 
sequence in P.v or P.k 
is either 1-5-8-14 or 1-
5-10, the residue 
positions are not 
conserved in this case.   
[FILVW]xxxxx
x[FILV]xxxxx[
FILVW] 
109 
       P.v  NGFRCAFSRFDVNFN 
       P.k  NGFKCAFSKFDVNFN 
74     P.f  NGFTCSINKLDVIFD 
 
     P.v  EKAVSIMLKNTSFTIE 
     P.k  EKALSIFLKNSSFSIE 
283  P.f  DKVFSTFLKNVTLLIE 
 
     P.v  FSVFFNSQLSRNHFSTV 
     P.k  FSVFFNSQLSRNHISTV 
355  P.f  FTIQFSSSLSRKHISTT 
 
 
    P.v  LLPFLGKMNFMDALGSLGLPPGLDLES 
    P.k  MLPFLNRMNFNEALGNLGLPSGLDIES 
416 P.f  TFPFFKNINSISGIGNVDIP-----KN 
 
 
    P.v  EEYKVRLMLELHNLRP 
    P.k  EEYKVRLMLELHNLRP 
109 P.f  EASLEFKNNLLEYMKGVMP 
CaM binding motif 1-
8-14, the 
corresponding 
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sequence in P.v and P.k 
is type 1-5-10. 
Rxx[S/T] 233  
P.v     DEHNPDAPNMQQSSYSFSSH 229 
P.k     EENNLDVPHVQ-SSYSFSSH 227 
P.f     DQKNNNMVPMENRSFSYSQQ 239 
 
This consensus motif is 
phosphorylated by 
CamKII; 
phosphorylation 
Ser/Thr; no 
modification required 
[S/T]x[K/R] 36 
 
P.v     EPEEINTITGKLQVQNSEHEKIL 48 
P.k     EPEEIKNITAKLQVQNSEHEKFL 47 
P.f     SAEAVHTLTAKLDTENKAHQKYI 49 
 
This consensus motif 
in peptide is 
phosphorylated by 
PKCalpha; 
phosphorylation 
Ser/Thr; no 
modification required 
[K/R]R 148 P.v      FFSELRRKFFHLYRNDESGQDGEGSSR  
P.k     FFSELRRKFFHLYRNNESNEDGDVNQN  
P.f     YFSELRRKFFQIYRDPNNKNQNEDNVD  
 
This consensus motif 
in mating factor is 
proteolyzed by Kexin2; 
cleaves after C-
terminal Arg; no 
modification required 
Table 3. Mini motifs were predicted in PfPV1 by MnM (Rajasekaran et al., 2009). 
There were 69 motifs found, only some highlighted motifs were listed here, based on 
the conserved region with other Plasmodium species, the surface prediction score (0.8 
– 1.0) and the cell localisation (consider PV localisation as the extracellular or 
secreted). In a consensus motif, redundant amino acids in a position are put inside 
square brackets; x is any amino acid. P.v: P. vivax; P.k: P. knowlesi; P.f: P. 
falciparum. The annotations of motif functions were extracted from the MnM 
homepage. 
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3.2. Strategy one: Gene targeting by double cross-over homologous 
recombination using a negative selection system 
3.2.1. Double cross-over integration of pHTK∆PV1 under the selection of 
ganciclovir still required WR99210 cycling 
 
In order to study the importance of PfPV1 in asexual P. falciparum life cycle we 
decided to knockout the encoding gene. To avoid the time consuming process of 
cycling of on and off WR99210 drug (WR), we decided to target the PF11_0302 gene 
by double crossover recombination with the negative selection strategy (Duraisingh et 
al., 2002). The 5’-flank and 3’-flank regions of PF11_0302 were respectively inserted 
into SpeI/BglII and EcoRI/NcoI site, in the same direction of expression of the 
hDHFR cassette of vector pHTK to create the vector pHTK∆PV1 (Figure 2.1). 
Transfectants were obtained after 21 days under the selection of WR99210. Three 
transfected parasite flask cultures containing the episomal plasmid were then put 
under the negative selection of ganciclovir by activity of TK encoded in the vector. 
Parasites were dead after adding ganciclovir and re-appeared in Giemsa stained 
smears at various times in subsequent culture: line 1 re-appeared after 12 days, line 2 
after 40 days and line 3 was unable to recover. To detect the integrating event, we 
carried out PCR reactions by combining a chromosome specific primer (Figure 3.2 A, 
primer a] or d]) with a vector specific primer (Figure 3.2 A, primer b] or c]). 
However, we failed to detect any integration (Figure 3.2 B, reaction [a + b] and [c + 
d]). In fact, the full length PfPV1 was still intact, evidenced by the product at 1.38 kb 
fragment (Figure 3.2 B, reaction [e + f]). Technically it might be the results from a 
mixed population of integrated and non-integrated parasites so both line 1 and line 2 
were cloned by limiting dilution. We were unable to obtain any single parasite clone 
from line 2, and only one clone, the 1D8 was picked from line 1. The genomic DNA 
was digested with XbaI and EcoRI and subsequently probed in Southern blot 
hybridisation with a 5’-end probe (Figure 3.2 C). However we were unable to detect 
any integration event, evidenced by the plasmid band (8.4 kb) and an endogenous 
band (4.1 kb) in the blot (Figure 3.2 C). 
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Figure 3.2. The PfPV1 locus cannot be targeted by simple negative selection. (A), 
Schematic representation of integration of the knockout plasmid pHTK∆PV1 into the 
chromosomal PV1 locus (Chr 11). The PfPV1 locus is flanked by two genes, PF11_0301 
and PF11_0303. PV1- 5 flank probe is depicted as solid line (▬); Enzymes used in 
southern blot were XbaI (X) and EcoRI (E). Primers used in PCR: chromosome specific, 
primer a] and d]; vector specific, primer b] and c]; primer for the amplification of PfPV1 
encoding gene: primer e] and f]. (B), PCR for the detection of integration, the expected 
product of reaction [a + b]: 2.4 kb; reaction [c + d]: 1.6 kb. Reaction [e + f] amplifies the 
whole PfPV1 encoding sequence at 1.38 kb as labelled in the picture. DNA templates 
were from 3D7 parental parasites (lane 1); episomal pHTK∆PV1 containing parasites 
shortly after visibly reappeared (lane 2); transfected parasite after adding ganciclovir, 
recovered after 12 days (lane 3), after 40 days (lane 4). (C), Southern blot of restricted 
genomic DNA from 3D7 parental parasites (lane 1), episomal pHTK∆PV1 containing 
parasites (lane 2), and the 1D8 clone (lane 5), the uneven black stain under the plasmid 
band at lane 1D8 was merely from the noise background of the blot, as it was from the 
same stain in the empty neighbour lane. The blot was probed with 5’flank fragment of the 
PfPV1, labelled by [α-32P]dATP. DNA markers are shown in kb.  Endogenous band (E): 
4.1 kb, episomal plasmid (P): 8. 4 kb.  
A 
B 
[a + b] [c + d] [e + f] 
PV1 
 1   2    3      4 1     2    3     4  1   2      3     4 
1 
1.65 
3 
4 
2 
0.65 
0.5 
0.1 
0.3 
1 
0.85 
1.65 
3 
4 
6 
9 
E 
P 
1 2 5 
C 
kb 
kb 
Results 
  
 67 
vAs the time requirement was not shortened by promptly adding ganciclovir, we 
returned to a traditional gene disruption protocol by drug cycling of positive selection. 
Parasites were subjected to three rounds of with or without WR over several months. 
Ganciclovir was also added after each cycle and simultaneously kept in the culture 
with other lines. Adding ganciclovir after 2 cycles of WR killed the parasites and the 
parasites visibly reappeared after 8 days, we named the population as 2 cyc-WG (ie, 
adding ganciclovir after 2 cycles of WR). The normal 3 cycles WR was still kept in 
culture and ganciclovir was also added afterward. At this point ganciclovir did not 
completely kill the population, there was a mix of dead and ill-looking parasites under 
the microscope. However, the parasitemia was recovered after 5 days and the culture 
was labelled as 3 cyc-WG population.  
 
To analyse the integration, we examined the genomic DNAs by Southern blots. 
Similar to the first attempt with the 1D8 parasite, after 3 cycles of WR without 
ganciclovir we were unable to detect any integration event (Figure 3.3 B, left panel, 
lane 2, 3 and 4). Alternatively, adding ganciclovir after 2 WR cycles caused the loss 
of the episomal plasmid band, as shown in Figure 3.3 B, lane 5, the disappearance of 
the 8.4 kb band. Interestingly, there was one smear at the expected size of integration 
(5.4 kb) although the endogenous band (4.1 kb) was still there. We supposed that this 
might refer to the mixed population between the integrated and non-integrated 
parasites. Assuming that the 3 cyc-WG parasites would also obtain the same result we 
did not repeat the blot for the mixed population but went directly to isolate single 
clones by limiting dilution. 4 clones were obtained: C2, C3, E10, and F8. Analysis 
revealed the presence of the 4.1 kb endogenous band, in addition to a size shift 
between 5 and 6 kb (Figure 3.3 B, middle and right panel), closely to the expected 
integration band. C2 clone gave a “supposed integration” signal slightly shorter than 
other clones. We concluded that by combination of WR cycling and the selection of 
ganciclovir, the pHTK∆PV1 did integrate into the chromosome, as shown in the 
integration band of 5.4 kb by the PV1 5-end probe.  
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Figure 3.3. The episomal pHTK∆PV1 only disappeared after adding ganciclovir to 
rounds of WR99210 cycling. (A), Schematic representation of integration of the 
knockout plasmid pHTK∆PV1 into the chromosomal PV1 locus (Chr 11). The PfPV1 
locus is flanked by two genes, PF11_0301 and PF11_0303. PV1-5’probe is depicted as 
solid line (▬). The REs used for diagnostic digest were XbaI and EcoRI. The stop 
codon at the end of 5-flank region was introduced. The expected sizes of hybridised 
bands with 5-end probe are indicated as 4.1 kb for 3D7 (wild type) and 5.4 kb for 
integrated parasite. (B), Southern blot of restricted genomic DNAs hybridised with 5’ 
probe. Lane 1, 3D7 parental parasite; lane2, episomal pHTK∆PV1 containing parasite, 
cycle 0 of WR; lane 3, pHTK∆PV1 parasite, WR-cycle 2; lane 4, pHTK∆PV1 parasite, 
WR-cycle 3; lane 5, 2 cyc-WG parasite, ganciclovir was added after cycle 2 of WR; lane 
P, signal from 0.5 µg digested pHTK∆PV1 plasmid. Because of the strong signal at 8.4 
kb from the plasmid (P), the control lane was removed from the membrane after the first 
exposure, drawn as the solid rectangle. Lane C2, C3, E10 and F8: single clone from 3 
cyc-WG population. Blots from the middle panel and right panel were independently 
performed. DNA markers were shown in kb. The arrow bar (←) highlights the 
integrated smear, letter E marks the endogenous band (4.1 kb).  
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3.2.2. pHTK∆PV1 integrated into chromosome but not in a simple double cross-
over or a 5’ or 3’ single cross-over. 
 
Giving that the endogenous band of the PV1 locus still appeared in 4 clones above, 
and the band corresponding to the integrated size also appeared, we predicted that the 
integration indeed occurred, but to identify the nature of the recombination, we 
carried out more hybridisation analysis with the PV1-3’ probe and the TK gene 
specific probe. The obtained signals were unexpected, and different from predicted 
results (Figure 3.4 B). Consistent with the result from 5’ probe, hybridising the 
XbaI+EcoRI-digested genomic DNA with the PV1-3’ probe also confirmed the 
disappearance of the episomal plasmid (8.4 kb) once ganciclovir was added after 2 or 
3 cycles of WR, as shown in Figure 3.4 B, right panel, lane 2, 3, respectively. The 3’ 
probe gave a band at approximately 4.2 kb in all parasite lines, referring to the 
endogenous gene locus. However, the expected 3.5 kb band of integrated DNA was 
not observed. It could be because of the single homologous recombination at the 5’ 
end that the size corresponding to the endogenous band of 3’ probe still exists. 
However, in that case there must be another band at around 7 kb from the plasmid 
backbone (schematic integration at Figure 3.5) but there was no such other band 
besides the endogenous size.  
 
If the single cross-over in either 5’ or 3’ end happened, the TK gene in the plasmid 
backbone would also integrate into the chromosome, therefore we carried out the 
hybridisation with the TK probe. In fact, we performed the experiment with the TK 
probe first, stripped the membrane and re-probed with the 3’ probe and collected the 
data for the 3’ probe as above. For the TK probe although the episomal plasmids were 
gone, the blots of those clones were all positive (Figure 3.4 B, left panel). However, 
the obtained sizes were decreased gradually along the time of drug cycling. The first 
cycle of WR gave the same signal as the plasmid control (8.4 kb), but the fragments 
were shorter after adding ganciclovir in the second and third cycle (Figure 3.4 B, left 
panel, lane 1, 2, 3). In all single clones, a strong but cloudy signal at the range of 5 to 
6 kb can be observed. A band shift was also observed in C2 compared to other clones, 
the same phenomena as with PV1-5’ probe. Noticing that the intensity of the TK 
signal was much stronger than the PV1-3’end signal, we measured the density by 
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Multigauge software (Fujifilm), the TK intensity was approximately from 2 to 3.5 
fold higher than that of the endogenous band (Figure 3.4 C).  
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The existence of the TK gene can be explained by a single cross-over event. But the 
obtained results were not consistent with the expected result. If the homologous 
recombination happened at 5’ or 3’ end of the target gene, the hybridized product with 
TK probe would give a size of 7 kb or 9 kb, respectively (Figure 3.5). Moreover, 
besides the endogenous or/and the integrated band, the 5’ probe and the 3’ probe 
would also give another signal at the same size as the TK probe for the plasmid 
backbone but there were no such signals. 
 
 
 
 
 
 
 
 
Figure 3.4. pHTK∆PV1 integrated into chromosome but not in a simple double 
cross-over or a 5’ or 3’ single cross-over. (A), Schematic representation of 
integration of the knockout plasmid pHTK∆PV1 into the chromosomal PV1 locus 
(Chr 11). The PfPV1 locus is flanked by two genes, PF11_0301 and PF11_0303. The 
RE used for diagnostic digest is shown (XbaI and EcoRI). Probes for southern blot 
were depicted as: 3 end probe: straight line with arrowhead (↔), TK probe: small 
grid box (
 
). The stop codon at the end of 5-flank region was introduced. The 
expected sizes of hybridized bands with 3-end probe were indicated as 4.2 kb for 3D7 
(wild type) and 3.5 kb for integrated parasites. (B), Southern blot of restricted 
genomic DNAs. The blot was first probed with the TK fragment (left panel), stripped 
and re-probed with 3-end probe (right panel). Lane as labeled in the figure: 3D7: 
wild-type parasite; 1, episomal pHTK∆PV1 containing parasite, cycle 1 of WR; 2, 
cycle 2-WG; 3, cycle 3-WG, DNA from this population was not high enough so the 
signal was weaker than the others’ ; Lane C2, C3, E10 and F8: single clone from 3 
cyc-WG population respectively. The strong signal at 8.4 kb from the plasmid control 
was cut off after the first exposure, drawn as the solid rectangle. Theoretically, the 
blot with TK probe would not give any signal once a double cross-over occurred, but 
the reaction happened in all clones here. (C), Density measurement of TK band vs 
PV1-3’ band. Signal intensity was measured by Multigauge Software (Fujifilm). E: 
PV1 endogenous band; TK/ PV1-3end probe: ratio of the TK signal vs PV1-3’ 
endogenous band. 
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Figure 3.5. Schematic representation of possible integration event of pHTK∆PV1 
into PV1 locus. (A), genotypic analysis of P. falciparum transfected with pHTK∆PV1. (I. 
∆PfPV1), disruption of PfPV1 by double cross-over integration; (II. ∆PfPV1-5’) and (III. 
∆PfPV1-3’), the single cross-over recombination event for one copy of the full length 
plasmid integrated into 5’ end or 3’ end, respectively. The PfPV1 locus is flanked by two 
genes, PF11_0301 (pale blue box, 301) and PF11_0303 (pale blue box, 303). The 
pHTK∆PV1 plasmid contain the Amp resistance cassette (AmpR, white), TK cassette 
(green), hDHFR (lavender) and 5’ (red) and 3’ (gold) homologous region of PfPV1. The 
NotI site marks a full circle of plasmid. The premature stop codon (STOP) was introduced 
into the 5’ region of PfPV1. Left arrow, transcription start site and the direction of TK 
cassette. The REs used for diagnostic digest were XbaI (X) and EcoRI (E). Probes for 
southern blot: 5’ probe, red box (▬); 3’ probe: gold line with arrowhead (↔), TK probe: 
green, small grid box (
 
). The expected sizes of diagnostic bands are indicated in kb. In 
the case of the EcoRI site in the cloning join between the hDHFR cassette and the 3’ 
region, the site is at the beginning of the homologous region and this site will not include 
in the cross-over recombination, hence it always sticks together with the hDHFR cassette. 
(B), Result and possible outcomes of the integration by southern blot with 4 different 
probes: PV1- 5’, PV1-3’, TK specific and DHFR probe. gDNAs were digested with XbaI 
and EcoRI. Upper, left panel, the obtained results; upper, right panel, expected sizes if a 
double cross-over occurred; Bottom, left panel, expected sizes if a single cross-over 
happened at the 5-end; Bottom, right panel, expected sizes if a single cross-over happened 
at the 3-end. At the result panel, the size of the integrated band with 5-probe was between 
5 and 6 kb and the exact size was not indicated, same went to the result from the TK 
probe.  
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3.2.3. The TK encoding sequence might still exist in the integrant but appears 
not to be active   
Despite adding ganciclovir, the parasites quickly recovered after a few days whereas 
the TK probe also yielded a positive signal in hybridisation (Figure 3.4). It is probable 
that either the TK activity was not efficient or there was no TK function at all. We 
carried out the PCR with TK specific primers and genomic DNAs from these clones. 
The primers TK gene F/R amplified a product of 605 bp from the 1131 bp coding 
sequence of TK gene. The TK probe was also from the same primers but with the 
DNA template from initial pHTK∆PV1 vector. For control, we used a pair of primers 
to amplify the full length PfPV1 coding sequence. The PV1 sequence was positive in 
all clones (Figure 3.6 B), confirming that the PV1 gene locus was not disrupted. 
Meanwhile, the PCR of TK specific primers yielded a questionable result, inconsistent 
with the Southern blot. The expected 605 bp fragment was positive in gDNAs from 
episomal pHTK∆PV1 containing parasite and mixed population of 3cyc-WG 
parasites. However, none of the clones yielded a product at 605 bp, but a faint band 
around 1 kb (Figure 3.6 A). We could not exclude the possibility that these are 
unspecific, but they only occur in gDNAs from single clones, not in gDNA from 
mixed population. Giving the fact that the integrated pHTK∆PV1 parasites survived 
in ganciclovir, the TK probe (amplified from the same specific primers) yielded 
positive results for the clones in Southern blot but not the correct size in the PCR, we 
assumed that somehow upon the integration into the chromosome DNA, the TK gene 
rearranged and caused no toxic effect to parasite on ganciclovir treatment. The 
inefficiency of the TK selection system has previously been reported [see Introduction 
1.5.2.2, (Duraisingh et al., 2003a; Maier et al., 2006)] with the explanation of 
insufficient TK activity from one copy upon single cross-over recombination. To our 
knowledge, this is the first report of a possible inactivation of the TK in the negative 
selection system in P. falciparum. In an attempt to analyse the sequence of the 1 kb 
fragment from the PCR above, we failed to clone them into subcloning pJET1 vector 
(Fermentas) and the event for TK was not further analysed.  
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3.2.4. Analysis of transfectants with the DHFR probe 
 
Probing the blot with the hDHFR probe revealed an ambiguous result. The hDHFR 
probe was amplified by DHFR probe F/R primers, encompassing the last 250 bps of 
hDHFR gene and 62 bps of hrp2 - 3’ region. Theoretically, the hDHFR probe would 
detect a 0.85 kb fragment from XbaI and EcoRI double digested DNA containing the 
hDHFR cassette (CAM 5’ – hDHFR gene – hrp2-3’) used in this study (see Figure 3.5 
for the schematic RE map). Indeed, there was no band at 3D7 parasite (Figure 3.7 B, 
lane 1), confirming the absence of hDHFR in wild type genome. The 0.85 kb 
fragment was observed in pHTK∆PV1 control, the episomal plasmid and the DNA 
from 2 and 3 WR cycles. Upon the negative selection by ganciclovir, the 0.85 kb band 
was invisible, as shown in 2 cyc-WG parasites and the single clones C2, C3, E10 and 
F8. The PCR with hDHFR probe primers were positive in all clones (Figure 3.7 A). 
Figure 3.6.  Inability to amplify the specific TK fragment from pHTK∆PV1-
integrated parasite clones.  (A), PCR by TK gene F/R primer, product: 605 bps. (B), 
PCR by PV1-XhoF/PV1-AvrR primers, amplify full length PV1, product at 1372 bps. 
Lane 1, 3D7 wild type parasite. Lane 2, episomal pHTK∆PV1 containing parasite. 
Lane 3, mixed population parasite after 3 cyc WR + Ganciclovir. Lane C2, C3, E10, 
F8: single clone, respectively. Lane (P), pHTK∆PV1 vector control. PCR components 
were followed standard conditions. PCR program: 35 cycles of 95oC/30 sec, 50oC/30 
sec, 68oC/ 1min 30 sec. The question mark depicts the unknown 1 kb product from 
single clones.  
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Thus the invisibility of the 0.85 kb fragment in Southern blot analysis is very likely 
because of the low copy number of hDHFR cassette once the plasmid integrated into 
the chromosome. As shown in Figure 3.7 B, the hDHFR signal was visible only in 
episomal plasmid containing parasites. There were other faint bands around 6 and 9 
kb in all pHTK∆PV1 containing parasites, presumably unspecific signals from the 
plasmid. Probing the blot from single clones with the hDHFR probe also revealed the 
band at 9kb. The size of pHTK∆PV1 is 9257 bp and hybridisation of the hDHFR 
probe with the digested pHTK∆PV1 control detected a specific band at 0.85 kb and a 
faint undigested plasmid signal slightly higher than the 9 kb band from genomic DNA 
of the clones (Figure 3.7 B, lane P). We do not speculate that the 9 kb band is the 
result from the integration into other gene locus than PfPV1. There are several reasons 
supporting this interpretation. First, the parasites resist against WR implicating that 
the hDHFR is fully active. Since the first XbaI site is inside the hDHFR gene it is 
unlikely that this site was altered. The second XbaI is next to EcoRI in the multiple 
cloning site of the original vector (see Figure 3.5 for the schematic RE map), meaning 
both two sites  are at the edge of the 3’ homologous region and naturally these sites 
will not be included in the cross-over recombination. Hence these regions always stick 
together with the hDHFR cassette. While EcoRI activity is affected by site 
preferences and star activity, XbaI is not. The digestion was completed as shown in 
the blot, hence in any possibility, episomal or integrated hDHFR cassette (even the 
unspecific integration) would always react with the specific probe to give a signal at 
0.85 kb. Moreover, if the integration happened at an unrelated gene locus, the PV1- 5’ 
and 3’ probe would detect other cross-reacted bands than the endogenous 4.1 kb/ 
PV1- 5’ probe (Figure 3.3), 4.2 kb/PV1 3’ probe (Figure 3.4) and the integrated band 
5.4 kb from the PV1- 5’ probe (Figure 3.3).  
 
To further confirm the targeting of pHTK∆PV1 into the right locus on chromosome 
11, we attempted to undertake the pulse field gel electrophoresis (PFGE) and 
hybridise the membrane with both PV1 probe and hDHFR probe. Unfortunately, at 
the point of this experiment, despite several trials, we failed to establish the PFGE 
condition and could not provide more evidence for the targeting of pHTK∆PV1 into 
the PfPV1 locus. Nevertheless, with all the analysed data above, we firmly suggest 
that the pHTK∆PV1 integrated into the PfPV1 locus on chromosome 11 in a manner 
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that maintained both the endogenous locus, introduced the WR resistance marker - the 
hDHFR gene as well as inactivated the TK gene.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7 Analysis of the integrated pTK∆PV1 into P. falciparum by the hDHFR probe. (A). 
A specific fragment of hDHFR (312 bps) was amplified in all clones, the primer pair hDHFR probe 
F/R was used for both PCR and for the probe in southern blot. 3D7: parental parasite; epi: episomal 
pHTK∆PV1 containing parasite (cycle 0 of WR); mix:  parasites in mixed population after adding 
ganciclovir into cycle 3 of WR; C2, C3, E10, F8: single clone, respectively; P: pHTK∆PV1 
plasmid control. The amount of DNA input might not be the same in all reactions therefore the 
product signal intensity also varies. (B). Southern blot with hDHFR probe. Lane 1, 3D7 parental 
parasite; lane 2, episomal pHTK∆PV1 containing parasite (cycle 0 of WR); lane 3, pHTK∆PV1 
parasite, cycle 2; lane 4, pHTK∆PV1 parasite, cycle 3; lane 5, 2 cyc-WG parasite, ganciclovir was 
added after cycle 2 of WR; lane P, signal from 0.5 µg digested pHTK∆PV1 plasmid. Because of 
the strong signal at 0.85 kb from plasmid, the lane was cut from the membrane after the first 
exposure. Lane C2, C3, E10 and F8: single clone, respectively. (C), overlap of the result from 
Figure 3.2 B (PV1 5’ probe) and Figure 3.6 B, left panel (hDHFR probe). The membranes for both 
probes were identical, P, plasmid band; I, integrated band; E, endogenous PV1 band; WR, hDHFR 
band. 
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3.2.5. The PfPV1 appears to be essential for asexual stage development of P. 
falciparum  
 
As shown in Figure 3.6 B, the full length PfPV1 protein encoding sequence is still 
intact, we checked the expression of PfPV1 protein by Western blot (Figure 3.8). All 
clones express a positive band at around 55kDa, similar to the wild type 3D7 parasite, 
indicating that the PfPV1 gene is fully expressed despite the integration of the 
transfected vector into the chromosome.  
 
 
 
 
 
 
 
From the Southern blot in Figure 3.3, we noticed that the signal intensity of the 
endogenous PV1 band is visibly equal to that of integrated band. We then carried out 
the quantitative Southern blot (Figure 3.9), comparing the signal of the endogenous 
band from the blot hybridised with the PV1-5’ probe and the signal from a probe 
against the single copy gene dihydropteroate synthase (DHPS). The intensities of the 
bands were determined by Multigauge Software Fujifilm (Figure 3.9 C). In PV1-5’ 
probed blot, the endogenous 4.1 kb fragment (E) and the integrated 5.4 kb band (I) 
were observed at close ratio 1:1 in all clones (Figure 3.9C). The same blot was 
stripped and hybridised with DHPS probe. We observed the 3 kb DHPS fragment in 
all parasites (Figure 3.9 B). Comparing the signal intensity of the DHPS fragment and 
the endogenous PV1 band we verified the single copy of the PV1 gene as well as the 
integrated band (Figure 3.9 C). We assumed that the parasite has duplicated the PV1 
locus before integration to accommodate both the selection cassette and the 
130 
3D7 C3 C2 E10 F8 
α - SERP 
α - PV1 
S     P S    P S        P S       P S        P 
55 
70 
95 
kDa 
Figure 3.8. Protein PfPV1 still expresses in pHTK∆PV1-integrated clones. A 
total of 1 × 107 cell equivalents were loaded and probed with anti-SERP as the PV 
marker and anti-PV1 antibodies. Size marker is shown in kDa. Cell fractionation by 
SLO was carried out as described in Material and Methods. S: supernatant from SLO 
lysis. P: pellet after SLO lysis, this fraction contains the PV and the parasite proteins.  
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maintenance of the endogenous gene. This suggests that PfPV1 has an important, if 
not essential function for P. falciparum during their erythrocyte development. 
Because of the importance of the gene, it is not easily possible to disrupt the 
endogenous locus.  
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3.3. Strategy two: episomal expression of PV1-GFP followed by integration 
into the endogenous PV1 coding region 
3.3.1. The episomal pHTK∆PV1 in the double transfected parasites only 
disappears after negative selection with ganciclovir 
 
As it appeared that the deletion of PV1 might be lethal, we designed a 
complementation experiment. We expected to be able to disrupt the endogenous gene 
locus through the pHTK∆PV1 vector and concomitantly express a copy of PfPV1 
from an episomal plasmid, which should not recombine with the endogenous gene 
locus. For this purpose, parasites already bearing the episomal pHTK∆PV1 were co-
transfected with the pARL-BSD-PV1g vector containing a Blasticidin S deaminase 
(BSD) cassette as selectable marker. The PfPV1 was fused to the N-terminus of GFP 
and the fusion PV1-GFP encoding sequence was controlled by the CRT-5 promoter 
(Figure 3.10A). Double transfected parasites were grown under blasticidin S pressure 
and cycles of WR99210. Using the fluorescent microscopy, we observed the glowing 
of the fusion PV1GFP protein and its localization in the PV (Figure 3.11 A). Thus the 
episomal PV1GFP transgene could be expressed in blood stage parasites. After 3 
cycles of WR, ganciclovir was added. Parasites were dead and re-appeared after 10 
days. We then isolated single clones by limiting dilution and carried out the Southern 
blot hybridisation.  
 
We first analysed the mixed population of double transfected parasites, using gDNAs 
from each cycle of WR (Figure 3. 10 B). The pARL-BSD-PV1g existing episomally 
can be detected at a 3.8 kb band with PV1-3’ probe as well as the BSD specific and 
the GFP probe. In all lanes except the wild type 3D7, we also observed the expected 
Figure 3.9. Quantitative southern blot confirms the single copy of endogenous 
PfPV1 locus after the integration. To ensure an equal loading, the blot was first 
probed with the PV1-5’ fragment (A), stripped and re-probed with the DHPS probe 
(B). The 648 bps DHPS probe was amplified by the pair of primer DHPS-F/DHPS-
R.(C), density measurement of PfPV1-related band. Signal from the endogenous 
band of PV1-5 end probe in each lane was compared with the respective lane at the 
DHPS probed hybridization by density measurement (Multigauge Software, 
Fujifilm). All the signal intensities were at closely 1:1 ratio, ensuring the single copy 
of PfPV1 gene. Lane 3D7; parental 3D7 cell line; lane C2, C3, E10, F8: single 
clones, respectively. E: PV1 endogenous band; I: integrated band; I/E: ratio of 
integration band vs PV1 endogenous band; DHPS/E: ratio of the single copy DHPS 
gene vs PV1 endogenous band. 
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1.2 kb fragment from pARL-BSD-PV1g plasmid when incubating the blot with PV1-
5’ probe. The PV1-5’ probe also gave a positive fragment of pHTK∆PV1 episome 
(8.4 kb band) even after prolonged more than 3 cycles of WR (Figure 3.10 B, lane 6). 
Similar to the pHTK∆PV1 single transfected (Figure 3.3 B, lane 5), in the double 
transfected parasites, the episomal pHTK∆PV1 band only disappeared once 
ganciclovir was added to the culture, as shown in Figure 3.10 B, lane 5, from the 3rd 
WR cycling population. However, the expected 5.4 kb integration band was not 
present; instead we detected a minor band of approximately > 2.5kb (Figure 3.10 B, 
5’ probe, lane 5 and 7). The possibility that this fragment is due to cross-reactivity 
between the PV1-5’ probe and the pARL-BSD-PV1g plasmid was ruled out because 
this band was absent from the WR cycling, non-ganciclovir population and from the 
control pHTK∆PV1 and pARL-BSD-PV1g plasmid.  
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3.3.2. The PfPV1 gene might act as selectable marker itself to maintain the 
pARL-BSD-PV1g vector when blasticidin S was removed 
 
In addition to isolate single parasites, another batch of post-ganciclovir population 
(DNA after 3 cycles of WR, added ganciclovir) was removed from blasticidin S 
pressure for more than 2 months. Surprisingly, the signal corresponding to the 
plasmid pARL-BSD-PV1g was still detected by all probes: PV1-5’, PV1-3’, GFP and 
BSD specific probe (Figure 3.10 B, lane 7). This phenomenon led to the question why 
parasites kept maintaining the BSD gene without the selection with blasticidin S. One 
possibility is, if PV1 is essential, and the endogenous locus is altered, the episomal 
copy may act as selectable marker itself and keep maintaining the pARL-BSD-Pv1g 
vector even though the drug pressure was already removed. Another interesting point 
is at the disappearance of the pHTK∆PV1 fragment, the intensity of the pARL-BSD-
PV1 signal was much stronger in comparison to the endogenous band (Figure 3.10 B, 
lane 5 and 7).   
 
 
Figure 3.10 Genotypic analysis of double transfected parasites with pHTK∆PV1 and 
pARL-BSD-PV1g vector. (A), Schematic representation of pARL-BSD-PV1g vector, 
pHTK∆PV1 vector, the wild type locus (3D7) of PfPV1 and the expected integration event. 
Details on pHTK∆PV1 vector and chromosome DNA are referred in Figure 3.5A. For pARL-
BSD-PV1g vector, the start codon ATG and the stop codon are displayed. The fusion PV1-
GFP protein was controlled by P. falciparum CRT promoter and P. berghei dhfr-ts 3’ UTR. 
Left to right arrow: the direction of BSD cassette. The RE used for diagnostic digest were 
XbaI (X) and EcoRI (E). Probes for southern blot are depicted based on pARL-BSD-PV1g 
vector: 5’ probe, open box (
 
); 3’ probe: solid line with arrowhead (
 
), BSD probe: 
solid box (
 
). For the rest of plausible event, see Figure 3.5A. The expected sizes of 
diagnostic bands are indicated in kb. (B), Southern blot of double transfected parasites with 4 
different probes: PV1- 5’, PV1-3’, BSD and GFP probe. The respective probe for the blot is 
labeled. gDNAs were digested with XbaI + EcoRI. Membranes were hybridised with PV1-5’ 
and GFP probe first, stripped and re-probed with PV1-3’ and BSD probe, respectively. Lane 
1, 3D7 wild type parasite; lane 2, lane 3 and lane 4, double transfected parasites after first, 
second and third cycle of WR, respectively. During  the period of WR cycling, parasites were 
always put under pressure of BSD. Lane 5, after three cycles of WR, ganciclovir was added, 
parasites found dead and reappeared after 10 days. Lane 6, double transfected parasites after 4 
cycles of WR, no ganciclovir; lane 7, parasites derived from lane 5, continued growing 
without BSD but WR and ganciclovir in 2 months. The strong signal from the plasmid 
controls might cause the noise background after prolonged exposure. We removed these lane 
after the first exposure and marked it as the solid signal, pTK for pHTK∆PV1 and pARL for 
pARL-BSD-PV1g vector; none other band out of the expected fragments was detected. E, 
endogenous band.  
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3.3.3. Single clones from double transfected parasites possess different 
genotypes 
 
We were able to isolate 19 clones (out of 96 wells) from the mixed population after 
adding ganciclovir into 3 cycles of WR parasites (continuously under the pressure of 
blasticidin S). This number of clones was acceptable considering that 30 parasites 
were seeded into the 96 well-microplate. Among these single lines, clones D3 and F9 
were the two slowest growing clones, especially D3 clone. This parasite line took 2 
weeks longer than other clones to have enough material for the first DNA extraction. 
The D3 clone did not react with anti-GFP antibody in the immunoblot and did not 
glow under the fluorescent microscope; hence it provided the evidence of loss of the 
pARL-BSD-PV1g vector in this line (Figure 3.11). For later experiments, we cultured 
the D3 clone without adding blasticidin S. On the other hand, the F9 clone only 
slowly grew at the beginning of recovering from the 96-microwell plate. Once the 
parasites fully recovered under the normal culture condition, the F9 parasite grew as 
normal as the others. The GFP expression of F9 clone was also confirmed by 
fluorescent microscopy and immunoblotting (Figure 3.11). We picked up B10 clone 
as representative for normal growth lines.  
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Figure 3.11. Not all clones from the double transfected parasites can co-express both 
PV1 and PV1GFP fusion protein. (A), Fluorescence microscopy of the mixed 
population of double transfected parasites and the B10 and F9 clone. The D3 clone did not 
glow and is not shown here. The nuclei were stained with Hoechst 33258 (blue). The 
PV1-GFP fusion protein was observed in a region surrounding the parasite (green). The 
merging of two colour channels was shown, as well the overlay with bright field (BF).  
(B), Immunoblot of double transfected parasite clones. A total of 1 × 107 cell equivalents 
after SLO fractionation were loaded and probed with anti-GFP or anti-PV1 antibody. Size 
marker is shown in kDa. PfPV1 protein is expected at 55 kDa but always appears slightly 
higher than its calculated MW. PV1GFP fusion protein is expected at ~80 kDa, GFP alone 
is around 26 kDa. In the blot with anti-GFP antibody, the parasite 3D7 did not react as 
expected. The dark signal on the 3D7 lane was from the haemoglobin contamination. D3 
clone also did not react with anti-GFP antibody, provided the evidence of loss of the 
pARL-BSD-PV1g vector in this line. The B10 and F9 clone both had the signal of 
PV1GFP fusion protein at ~80 kDa and the degraded GFP signal at ~26 kDa. In the blot 
with anti-PV1 antibody, the endogenous PfPV1 protein was observed in all lanes and the 
fusion PV1GFP protein was only detected at B10 and F9 clone.  
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From the fact that the mixed population kept BSD without drug pressure even after 2 
months, we removed blasticidin S on clonal parasites for 3 weeks and analysed by 
Southern blot. Genomic DNAs were collected right after 3 weeks of non-blasticidin. 
We continuously applied the WR pressure during the removal of blasticidin S. 
Because of time limitations, we only carried out the Southern blot using PV1-5’ and 
TK probes. In agreement with mixed population, single clones F9 and B10 in PV1-5 
probed blot gave a strong 1.2 kb signal from pARL-BSD-PV1g backbone vector even 
after 3 weeks of blasticidin S removal (Figure 3.12 A). The unknown >2.5 kb band 
which appeared at mixed population (Figure 3.10, PV1-5’ probe, lane 5, lane 7 and 
Figure 3.12 A) also occurred in both clone F9 and B10. There is one band at ~5kb 
from the F9 culture before blasticidin removal. This uncharacterised band also 
occurred in the pARL-BSD-PV1g control lane in this particular blot. Because the 
control was directly loaded from the digested plasmid and the identical initial plasmid 
sample had been used for the blot in Figure 3.10 had previously shown to result in 
only the 1.2 kb fragment (Figure 3.10, PV1-5’ probe), we considered this ~5 kb signal 
merely a cross-reaction which occurred only in this current experiment. Southern blot 
of clone F9 showed an ambiguous result, especially the high molecular weight and 
fuzzy bands at unknown sizes detected before the removal of blasticidin S (Figure 
3.12A, F9 clone). These bands were absent from both populations of B10 clone ( with 
or without blasticidin S). However, after removing blasticidin S, the F9 clone gave the 
same result as B10 clone. Due to the time limitation, we did not further investigate if 
the blasticidin S reversion could cause any effect on the double transfected parasites.  
 
The D3 clone has obviously lost the pARL-BSD-PV1g vector since the 1.2 kb band 
disappeared. Interestingly, while losing the episomal PfPV1 copy, the D3 clone 
displayed a similar pattern to parasites with single transfected pHTK∆PV1: a band at 
the same size of the endogenous PfPV1 gene (4.1 kb) and another band at integrated 
size (5.4 kb) (Figure 3.12 A, PV1-5’ probe). Moreover, while the TK gene 
disappeared at F9 and B10 clones, faintly presented at mixed population, it appeared 
at D3 clone in the same pattern of pHTK∆PV1 single transfected parasite (Figure 3.12 
B). The disappearance of TK in the F9 and B10 clone led to the assumption that the 
negative selection indeed created a pressure to force the integration of pHTK∆PV1 
removing the TK encoding gene. However, the integration might not happen at the 
right locus because the expected fragment (5.4 kb) was not observed.  
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Integration PCRs were also performed but no product was obtained despite the 
combination of alternative integration specific primers. To further analyse the 
genotype of the double transfected parasites, we performed PFGE and the blot was 
first probed with PfPV1 probe and Exp-1 probe as control of a gene locus on 
chromosome 11 (Figure 3.12 C). We have planned to strip the blot and re-hybridise 
the blot with the hDHFR probe and the BSD probe. However, because of the time 
consuming required for completely removing the old probe, these analyses could not 
be carried out. The DNA blocks used for the PFGE were from blasticidin-treated F9 
clone and non-blasticidin D3 clone. The PV1 internal probe using in the PFGE 
confirmed that the PfPV1 gene was undisrupted on chromosome 11 in both double 
transfected F9 clone and D3 clone which share the same genotype as pHTK∆PV1 
transfected parasite. The PfPV1 internal probe can also detect the PfPV1 sequence in 
the entire pARL-BSD-PV1g plasmid. We suggest that the smeary pattern on F9 clone 
was from the pARL-BSD-PV1g plasmid. Whether that pattern was from the episome 
or integrated pARL-BSD-PV1g into another chromosome was difficult to differentiate 
and require more controlled probes. Unfortunately, due to time constraints, we did not 
continue with these analyses. 
 
With these data above, once again, it is confirmed that the PfPV1 gene locus is not 
easily disruptable. Although there is the episomal copy of the gene in double 
transfected parasites, it is not controlled by the endogenous regulators. Moreover, the 
PfPV1 was fused to GFP and this might affect function of the protein. Hence, the 
over-expressed fusion protein might cause negative effect or unable to fully 
complement the endogenous gene. We therefore conclude that the PfPV1 plays an 
essential function in erythrocytic development of P. falciparum.  
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Figure 3.12 Single clones from double transfected parasites display different 
genotypes. (A), Southern blot with the PV1-5’ probe. Lane 3D7, wild type parasite; 
Mix, parasites after three cycles of WR99210, + ganciclovir, + blasticidin S; F9, D3, 
B10, single clone isolated from the mixed population, respectively. (+), blasticidin S 
was continuosly applied on the culture; (−), blasticidin S was removed from the culture 
in 3 weeks. The signal from 1.2 kb fragment of episomal pARL-BSD-PV1g plasmid 
was too strong thus the respective part on the membrane was removed after the first 
exposure. Even though, the intensified band can still be observed here. (B), Southern 
blot with TK probe confirmed for the first time the loss of TK gene. DNA samples as in 
blot A, except this time all the DNAs from clones were from (+) blasticidin S – treated 
parasites. pTK signal from pHTK∆PV1 backbone and pARL for pARL-BSD-PV1g 
vector; E, endogenous band; noise: the cross-reacted signal from the hybridization. The 
band at >2.5 kb was presented with a question mark. (C). PFGE analysis of F9 and D3 
clone. Exp1 probe is used as a control of chromosome 11. The PV1 internal probe was 
specific for intact PfPV1 encoding sequence hence it occurs on endogenous locus and 
the episomal copy from pARL-BSD-PV1g. PFGE condition as shown in Material and 
Methods.  
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3.4. Identification of interaction partners of PfPV1 by GST pull-down assay 
In order to identify proteins that interact with PfPV1, in previous experiments we had 
studied the immunoprecipitation and blue native PAGE (Nyalwidhe, unpublished 
data) but none of these identified any interaction. Here we carried out the pull-down 
assay of the recombinant PfPV1-GST fusion protein and the parasite extract.  
 
3.4.1. Purification of the recombinant PfPV1-GST protein 
The recombinant PfPV1-GST fusion protein was over-expressed in E. coli (Material 
and Methods). The fusion protein was partially insoluble (data not shown) but the 
soluble portion was much higher. We purified the soluble fraction following the 
instruction from the manufacturer (Material and Methods). The purified PfPV1-GST 
was obtained at apparent 80 kDa (Figure 3.13 A). Antibody to GST recognized both 
the PfPV1-GST fusion protein and the degraded GST (Figure 3.13 B). We used this 
purified protein for further experiments.  
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Figure 3.13 Purification of PfPV1-GST 
fusion protein. (A) SDS−PAGE of purified 
PfPV1-GST fusion protein. (B) Western blot, 
with anti-GST antibody. Lane TL, total lysate 
from E. coli cell pellet. The pellet was 
resuspended, lysed, separated by 
centrifugation and the supernatant was further 
purified (Material and Methods). Lane E, final 
elution after purification. Sample amount was 
loaded equivalent to a volume of 200µl of 
initial bacterial culture. Protein ladder is 
displayed in kDa. PfPV1-GST fusion protein 
was expressed at approximately 80kDa, 
pointed at arrow bar. The 26 kDa signal on 
panel B was from the degradation of GST 
alone. Anti-PfPV1 antibody also recognised 
the PfPV1GST fusion protein, but because of 
the high background blot, the data is not 
shown here.  
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3.4.2. GST pull-down assay was not able to detect any interaction 
To identify PfPV1 interacting proteins we used the chimeric PfPV1-GST protein as 
bait in the GST pull-down assay. Late trophozoites of 3D7 parasites were fractionated 
by SLO and the soluble proteins after SLO (SLO-SF) were incubated with the PfPV1-
GST protein, along with the control of GST protein and the Glutathione Sepharose 4B 
beads. We did not detect any distinguished band in three samples, except for some 
fragments containing PfPV1 peptides exclusively appeared at the PfPV1-GST 
containing test tube (Figure 3.14A, band number 1 and 3), probably the degraded 
product from PfPV1-GST. The parasite extract was also cross-reacting with the 
Glutathione sepharose beads since bands were observed at the test tube of parasite 
extraction bound to beads without bait protein (Figure 3.14, laneΦ). We analysed 
some most abundantly identical bands, they were PfEF (band number 2) and 
PfGADPH (band 4). To increase the sensitivity of the assay, we labelled the parasite 
proteins with 35S- Methionine. However, we still did not detect any difference, and the 
cross-reacting bands were identical in all samples. Therefore, at this point, under the 
conditions of this experiment, we cannot detect any interacting partners of PfPV1.  
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Figure 3.14 GST pull-down assay of PfPV1-GST fusion protein and parasite 
extract from SLO pellet did not detect any interacting proteins. Three test tubes 
were prepared for the assay, each tube contained Glutathione Sepharose 4B beads, 
SLO supernatant extracted from 2 x 108 parasites and the chimeric PfPV1-GST 
protein (lane +PV1-GST), GST protein (lane +GST) or beads without bait protein 
(lane Φ). (A) Coomasive gel prepared for mass spectrometry, parasite proteins were 
not labeled.   Bands were identified by Mass spectrometry: 1. PfPV1; 2, PfEF; 3, 
PfPV1; 4, PfGADPH. The PV1-GST fusion protein and GST protein in the test tube 
were marked with arrow. Protein ladder was shown in kDa. (B) X-ray film exposure 
from pull-down assay with 35S- labeled parasite proteins also gave identical bands in 
all test tubes.  
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4. Discussion 
 
Malaria is one of the most lethal infectious diseases worldwide. Understanding the 
biology of the causative agent Plasmodium will lead to better control of the disease. 
The biogenesis and maintenance of the parasitophorous vacuole within the infected 
erythrocyte is an essential factor for parasite survival. The PV has been postulated to 
be involved in various pivotal functions, however little is known about the PV 
contents and their respective functions. Our group had previously provided the first 
PV’s proteome research (Nyalwidhe and Lingelbach, 2006) and has continuously 
exposed more members of this important compartment. Among several hypothetical 
proteins found in the first round of analysis, there were two proteins predictably 
containing a signal peptide, hence in agreement with being exported from the parasite, 
adding further support to the validity of our data (Nyalwidhe and Lingelbach, 2006). 
The protein PfPV1 encoded by PF11_0302 gene was further analysed and its location 
inside the PV was confirmed biochemically and morphologically [(Nyalwidhe and 
Lingelbach, 2006) and unpublished data]. In order to address the function of this 
protein we used a gene knock-out strategy by double-crossover and a negative 
selection (Duraisingh et al., 2002). We also searched for the interacting proteins of 
PfPV1 using the GST pull-down assay.  
 
4.1. PfPV1 knock-out studies 
 
For the knock-out strategy, we used the negative selection strategy to select the 
double-crossover recombination. Initially we did not obtain any integration event after 
the first trial with ganciclovir selection without WR cycling. Therefore we put the 
knock-out construct transfected parasites on three WR cycles and added ganciclovir 
afterward. This time we were still unable to delete the encoding gene of PfPV1 
protein but interestingly we obtained both endogenous and knock-out band from the 
specific Southern blot hybridisation and the episomal plasmid was also eliminated 
(Figure 3.3). Our data also showed that the TK encoding sequence was maintained in 
the parasite despite the ganciclovir pressure. Concerning the target gene, the same 
phenomenon was also observed in previous report (Maier et al., 2008). The authors 
did a large scale gene knock-out work for 83 genes, using the same double-crossover 
strategy with both pHTK (Duraisingh et al., 2002) and ScCDUP system (Maier et al., 
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2006). There were 3 genes that gave the exact pattern as our result, showed both wild-
type and knock-out bands. Maier et al did not describe more details about the problem 
but went to the same conclusion with ours, that the targeting into the endogenous loci 
was accompanied by a duplication event for maintaining expression of the gene. We 
concluded that the PfPV1 gene is essential for in vitro growth.  
 
Our suggestion was further validated by complementing experiment, although the 
results were confused at the first look. We were not able to obtain the knock-out 
parasites. Instead we collected various parasite lines with different genotypes in 
respect of foreign constituents from transfected vectors. There was one clone, the D3 
clone which lost the complementary copy of PfPV1 displayed the same genotype as 
the single transfected pHTK∆PV1 parasite clones (Figure 3.12). The D3 clone also 
kept the TK encoding sequence and displayed both the endogenous and integrated 
fragment. Meanwhile, the F9 and B10 clone, which expressed the episomal 
PfPV1GFP fusion protein, lost the TK and did not generate the correct integration 
band but integrated into somewhere instead (Figure 3.12).  
 
At a brief look, it was somewhat a surprising result.  However, it could be interpreted 
in several ways. It could be that the intracellular concentration of PfPV1 is important 
for the parasites. The episomally chimeric PfPV1-GFP protein was controlled by CRT 
promoter but not PfPV1’s endogenous promoter. Although the localisation of 
PfPV1GFP protein in the PV was confirmed by microscopy and biochemical 
experiments, the expression profile could also affect protein activity. Data extracted 
from PlasmoDB show that, whereas both CRT and PfPV1 are expressed throughout 
the erythrocytic development stages, the expression intensity percentile of PfPV1 is 
always kept at a constant level in respect to the spectrum of all expression intensities 
at one time point (Figure 4.1). Moreover, the PfPV1 was fused to GFP and this might 
affect function of the protein, thus not strong enough to completely compensate the 
function of the endogenous one. One interesting result is when the episomal 
pHTK∆PV1 fragment disappeared, the intensity of pARL-BSD-PV1 signal was much 
stronger than the endogenous PV1 and persistently maintained even after the removal 
of blasticidin S (Figure 3.9 B, lane 5 and 7). It might be because the parasite needs 
time to gain enough copies of the episomal PV1 to keep a proper function.  
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From the results of F9 and B10 clone, we suggested that the episomal expression was 
limitedly complementing the activity of PfPV1, at least in low level. In these two 
clones, the loss of the TK cassette is an evidence of losing the full length pHTK∆PV1 
backbone. We assumed that, under the pressure of negative selection of ganciclovir 
and to keep the parasite resistant to WR, the hDHFR cassette and a possibly unknown 
part of pHTK∆PV1 must recombine into the parasite chromosomes to eliminate the 
TK cassette. Therefore the unexpected 2.5 kb band (Figure 3.12A) was probably from 
an unspecific integration which at this point was not identified. We supposed that at 
the critical point, some parasites did not duplicate the endogenous PfPV1 locus 
because of the limitedly complementary expression from episomal copy, as happen in 
F9 and B10 clone. Conversely, some other parasites, such as D3 clone, for unknown 
reasons lost the episomal copy of PfPV1, and had to duplicate the endogenous locus to 
maintain the expression and obtained the same genotype as single pHTK∆PV1 
transfected parasites (Figure 3.12).  
 
Overall, we were unable to disrupt the PfPV1 gene, however the integration did 
happen when the gene was duplicated (Figure 3.9). These data support our suggestion 
that the PfPV1 is essential for the survival of erythrocytic parasites. One might argue 
that further data need to be performed to ensure that the locus is open to 
recombination. We have independently transfected into 3D7 parasite two replacement 
plasmids. The pARL∆PV1g plasmid contains a fragment of PV1 gene fused to GFP 
yet the CRT promoter region is removed from the vector. Only upon the integration 
into the PV1 locus would the GFP express under the endogenous PfPV1 promoter. 
The second knock-in construct is the pARL-mutPV1 plasmid bearing two silent 
mutations at the very end of the PV1 gene. Through the WR cycling we suppose that 
the single homologous recombination would happen at the PV1 locus and the 
integration would be detected by sequencing, the transfected parasites are on culture 
now. Currently we are also collecting the DNA blocks for PFGE followed by 
Southern blot to monitor the chromosomes of both experiments:  the single and 
double transfected parasites. 
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4.2. A possible genetic re-arrangement by integrated parasites to inactivate 
TK activity 
Several major problems of gene targeting by single cross-over recombination strategy 
were time consuming by cycles of on/off positive drug selection and in some 
instances, the persistence of episomal concatamer. It is well established that the 
episomal plasmids are lost rapidly in the absence of drug selection as they are 
separated unevenly amongst the daughter parasites whereas the plasmids integrated 
into the genome are segregated normally with each chromosome (O'Donnell et al., 
2001; van Dijk et al., 1995). The unstable nature of the episomally replicating 
plasmids can be exploited to isolate rare parasites in a transfected population that 
possess integrated forms. Drug cycling ensures that after subsequent on/off drug 
cycles, all transfected P. falciparum parasites obtained had integrated the plasmid by 
single cross-over homologous recombination. However, in instances where gene 
targeting is not favoured, transfected plasmids can change to stably replicating forms 
(SRFs) that are maintained episomally in the absence of drug selection (O'Donnell et 
al., 2001). These SRFs are large concatamers of the parental plasmids, comprising 
A 
B 
Figure 4.1 Expression profile of PfPV1 (panel A) and CRT protein (panel B). 
Profiles were taken from PlasmoDB (www.plasmodb.org). Shown is the percentiled 
expression level of the respective gene relative to all other genes at a time point. Data 
in green are of parasites synchronised by sorbitol, in purple of parasites synchronised 
by temperature and in grey is data below the confidence threshold. Data for 
gametocytes were obtained by sorbitol synchronisation and sporozoite data represent 
an average of two replicates. Abbreviations: S, sporozoite; ER, early ring; LR, late 
ring; ET, early trophozoite; LT, late trophozoite; ES, early schizont; LS, late schizont; 
M, merozoite; G, gametocyte 
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from 9 to 15 plasmids in a head-to-tail array. The SRF DNA, although absent of 
single origin of replication, is effectively segregated between the daughter merozoites 
even in the absence of pressure selection. And it was proved that the replication 
happens through both rolling-circle and recombination dependent mechanisms 
(O'Donnell et al., 2002). Thus even after several cycles of positive selection, the 
episomal concatemer might still exist and prevent the homologous recombination. To 
overcome these limitations, we used the negative selection system by the activity of 
TK gene (Duraisingh et al., 2002). The TK enzyme converts prodrug such as 
ganciclovir to toxic metabolites. In principle, the only survival parasites were those 
with integration by double cross-over recombination, thus deleting the TK cassette 
and incorporating the positive drug marker into the target locus.  
 
The ideal advantage of negative selection by TK activity was initially thought to avoid 
drug cycling and to eliminate the plasmid backbone (Duraisingh et al., 2002), but 
there have been reports that the drug cycling of positive selection were also required 
(Kadekoppala et al., 2008) and that some gene disruptions using the TK system have 
resulted in the absence of double crossover while maintaining the episomal plasmid or 
single crossover with insertion of the full plasmid including the TK gene (Duraisingh 
et al., 2003a; Maier et al., 2006). Our experiments also evidenced that we could not 
get the integration when adding ganciclovir right after the transfected population was 
recovered. The integration only happened when negative selection was applied on 
parasite population after several cycles of WR (Figure 3.3), yet the TK sequence was 
still detected by Southern blot, but not at the specific size by PCR (Figure 3.6). 
 
The fact that pHTK∆PV1 clones survived after adding ganciclovir while losing the 
episomal plasmid but still harbouring the TK encoding gene was explained by Maier 
as the insufficient expression of TK enzyme from one copy of the gene for potent 
negative selection (Maier et al., 2006). From our data, we came to a disagreement 
with the speculation of integrating one copy of the TK gene into chromosome. Given 
that the integrated PV1 and the endogenous PV1 locus is at 1:1 ration (Figure 3.9), the 
density measurement of the signal in Figure 3.4 showed that the TK signal was 
stronger 2 to 3.5 fold compared to the endogenous signal and, therefore, the integrated 
PfPV1 band. Moreover, according to the first TK negative selection report in 
Plasmodium, the transfected parasites exhibit a marked “bystander effect” on addition 
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of ganciclovir (Duraisingh et al., 2002). The “bystander effect” is the phenomenon 
when the neighbouring cells not expressing the negative selectable markers are killed 
alongside those expressing them. Therefore it is unlikely that the TK activity was not 
sufficient. We supposed that the concatameric plasmid was integrated into the parasite 
genome in multiple plasmid backbones. We were unable to amplify a 605 bp specific 
TK fragment in single clone parasites, but a ~1 kb band (Figure 3.6 A, clone C2, C3, 
E10 and F8). In the existence of SRF concatamer, no evidence of sequence 
rearrangement or additional sequence was detected (O'Donnell et al., 2001) and our 
Southern blot also proved that the original TK was still intact in the epsiomal plasmid 
containing parasites (Figure 3.6, lane 2 and 3, mixed population). We assumed that 
upon integrating, the parasites re-arrange the TK-related sequence to inactivate its 
activity, therefore prevent the lethal effect from converting ganciclovir to toxic 
metabolite.  
 
The genetic rearrangements to inactivate TK gene had been reported at high frequency 
in the murine leukemia virus-based vector (Parthasarathi et al., 1995; Varela-
Echavarria et al., 1993) used in mammalian cell culture research, not surprisingly 
because of the nature of retrovirus-based system. In a closer parasitic system, Valdés 
et al. while testing TK gene as a negative selection system for Trypanosoma brucei 
reported the loss of TK activity due to the occurrence of point mutations and 
frameshifts (Valdes et al., 1996). So far there has been no detailed explanation on 
problems of applying TK negative selection in Plasmodium. We report here for the 
first time a possibility of genetic rearrangement of this negative selection marker on 
transfected DNA upon the integration. It would be clearer if we successfully cloned 
and sequenced the unspecific ~1kb band appeared in our transfected clones (Figure 
3.6). In the content of this thesis, we did not further analyse this event.  
 
4.3. Blasticidin S resistance 
Blasticidin S has been successfully used in many P. falciparum genetic transfection 
experiments (Mamoun et al., 1999; Sidhu et al., 2002; Wang et al., 2002). In these 
studies, transfected parasites were selected through expression of the Aspergillus 
blasticidin S deaminase (BSD), which converts blasticidin S to a nontoxic 
deaminohydroxy derivative. We were surprised when the D3 clone derived from the 
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double transfected parasites lost the BSD-containing vector but still survived under 
the blasticidin pressure. Although very weak and slowly grown, the D3 clone was able 
to maintain a parasitemia enough for visibly detected under the microscope. After we 
detected the positive clone in limiting dilution, to collect enough parasite material for 
DNA extraction, the D3 clone was 2 weeks delay to other clones. Fluorescent 
microscopy, immunoblot and Southern blot confirmed the loss of pARL-BSD-PV1g 
vector in this clone (Figure 3.11 and 3.12, lane D3). Recently, the problem of 
blasticidin resistance in P. falciparum studies has also been reported (Hill et al., 
2007). The authors, when attempting to generate a genetic disruption in the FCB 
parasite, ended up in blasticidin S-resistant parasites that lacked the BSD sequence 
from the transfection plasmid. After some experiments these authors concluded that a 
mutation in the plasmodial surface anion channel (PSAC) was responsible for 
blasticidin resistance. They envisioned that the selected changes in PSAC serve to 
alter its selectivity profile and prohibit blasticidin S access to its intracellular target. 
However, that resistance could be generated only from the FCB parasite, not from 
other parasite isolates used in their experiments (HB3, W2, and 7G8). The authors 
proposed that the FCB isolate presumably carries a permissive genetic background for 
the selection of required changes in PSAC.  
In our case, it is possible that the D3 isolate also generated some alteration in its 
background thus resistant to blasticidin S. We could not answer whether its resistance 
was from the altered PSAC or else. So far there has been no report of blasticidin S 
resistance in the 3D7 parasite isolate. However, in our group we also observed some 
blasticidin S tolerantce occurred only in 3D7 parasites already bearing an hDHFR-
containing vector (Spork and Baser, personal communication). We therefore agree 
with Hill’s statement, that the acquisition of blasticidin S resistance may require 
multiple changes at the level of the parasite genome. Therefore, even though the 
blasticidin S has shown the limitation to its use in transfection, so far the problem has 
only been observed in the unique background parasites. Given the usefullness of BSD 
application in many P. falciparum single transfections, we suggest that the use of 
blasticidin S is still reliable in meticulously analysed data.  
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4.4. Identifying interaction partners 
In an attempt to identify interacting proteins with PfPV1 by GST pull-down assay, we 
performed experiments with proteins from trophozoite-stage parasites. Unfortunately, 
we did not detect any protein partner (Figure 3.14). Not shown in the content of this 
dissertation, but in immunoprecipitated studies, blue native PAGE or pull-down assay 
with His-tag recombinant, PV1 protein also yielded no interaction (Andrea 
Ruecker/2007 and Caroline Odenwald/2008, bachelor thesis).  
 
Aside from the proteomic data in our group (Nyalwidhe and Lingelbach, 2006), 
PfPV1 has been spotted in LaCount’s network (LaCount et al., 2005) where the 
authors identified P. falciparum protein–protein interactions using a high-throughput 
version of the yeast two-hybrid assay (Y2H). They performed more than 32,000 yeast 
two-hybrid screens, of which 11% yielded positives in which the identities of both 
interacting protein fragments were determined. Six interactions were identified for 
PfPV1. There are three conserved, unknown function proteins encoded by 
PF14_0649, PFI0175w, PF11_0160 and other three proteins encoded by PF14_0197 
(zinc finger protein, putative), PFB0300c (Merozoite surface protein 2 – MSP2) and 
PFE1590w (early transcribed membrane protein 5 – ETRAMP5) (Figure 4.2), 
whether or not these interactions are true positive require further investigation. 
Recombinant expression of the proteins mentioned above and in vitro binding 
between the individual proteins with PfPV1 might help to confirm the interaction. In 
our pull-down assays and in the previous experiments, we only examined the parasite 
extraction at trophozoite stage, particularly at the late trophozoite. Given the fact that 
in the whole asexual parasite cycle, the PfPV1 gene is expressed at high level in the 
spectrum of all expression intensities (Figure 4.1A), we could not rule out the 
possibility that the proteins above are only interacting with PfPV1 in a certain time 
point. Because our data do not cover all of the stages, we temporarily could not state a 
conclusion about the interacting proteins.  
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PF11_0160 
PF14_0197 
zinc finger 
protein, 
putative 
PF14_0649 
Conserved protein, unknown 
function (merozoites mass spec 
peptide/containing Galactose oxidase 
central domain, Kelch2_Kelch motif 
and an ATPase domain of HSP90 
chaperone) 
 
PFI0175w-a 
Conserved protein, unknown 
function  (merozoites mass spec 
peptide/ late expression profile, 
containing  prefoldin domain  
Conserved protein (contain a 
putative methyl transferase 
domain/SET domain superfamily/ ion 
metabolism and transport and a TPR-
like superfamily domain/ 
Tetratricopeptide repeat (TPR), 
protein interaction) 
PFB0300c  
merozoite 
surface protein 
2 (MSP2) 
precursor 
PFE1590w 
early transcribe membrane 
protein (ETRAMP5, PVM 
localisation) 
 
 
 PfPV1 
Figure 4.2  Y2H interactions of PfPV1 (LaCount et al., 2005). Data was based on the 
protein interaction network for P. falciparum derived from yeast two-hybrid studies. 
Information of the interacting partners was provided in the box, collected from 
PlasmoDB (www.plasmodb.org) (Aurrecoechea et al., 2009). Blue:  PfPV1 was prey; 
Red: PfPV1 was bait in the Y2H study.  
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4.5. Conclusion: PfPV1 – a conserved, unique protein with unknown but 
essential function 
 
The P. falciparum genome predictably contains at least 5,409 open reading frames 
(ORFs) but over 60% lack sequence similarity to genes from any other sequenced 
organism (Gardner et al., 2002). Also, detection of over 2,400 proteins by mass 
spectrometry showed that a large number of those hypothetical ORFs are transcribed 
and validated (Sam-Yellowe et al., 2004). Thus, almost two third of the plasmodial 
proteins appear to be unique to this organism. Defining putative roles for these 
unannotated ORFs in the absence of homologs in other organisms remains 
challenging, discovery of their roles and identification of Plasmodium specific key 
regulatory elements will be fundamental to control this important pathogen.  
 
PfPV1 is one of the unannotated proteins specific in Plasmodium. Location in the PV, 
unable to knock out, this protein also does not include any known functional domain, 
thus making the elucidation of its function is more difficult. At this point we can only 
present some predicted functions of PfPV1 through bioinformatics research, although 
the obtained scores are rather low (Table 3). We also present here the data extracted 
from PlasmoDB in searching for genes that have a similar expression profile to PfPV1 
(Table 4). Of 100 defined matches, there are 13 genes predictably contain a signal 
peptide, half of their products are unknown function proteins, the others encode 
various products, from phosphatase to protease or multi-transmembrane proteins. The 
top 3 genes that score the highest profile similarity to PfPV1 but do not contain a 
signal peptide all encode for metabolism transporters: PFE1150w - the multidrug 
resistance protein, PFA0375c – the lipid/sterol:H+ symporter and PFF1430c - a 
putative amino acid transporter (Table 4). The hypothesis that genes with similar 
functions have similar expression profiles has been widely considered as one of the 
methods in finding gene's cellular role in Plasmodium (Le Roch et al., 2003). 
Although those clues are not the clarified hints but deserved to further exploration to 
understand the biological function of PfPV1. Extending the PfPV1 interaction assays 
to the whole erythrocytic stages could help to define the function of PfPV1. 
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Table 4. Expression profiles similarity to PfPV1 
 
No. [Gene] [Profile Distance] [Annotated GO Function] [Product Description] 
[SignalP 
Peptide] 
 PF11_0302 0 N/A conserved,   unknown function Y 
1 PF14_0201 1.1811 molecular_function surface protein, Pf113 Y 
2 PF14_0614 1.2541 hydrolase activity phosphatase, putative Y 
3 PF11_0246 1.3042 molecular_function conserved, unknown function Y 
4 PFC0450w 1.3604 N/A conserved  , unknown function Y 
5 PFE1340w 1.438 N/A conserved, unknown function Y 
6 PFL0065w 1.4732 molecular_function conserved, unknown function Y 
7 PFL0790w 1.5361 molecular_function conserved, ABC transporter 
transmembrane domain, 
unknown function 
Y 
8 PF11_0174 1.5644 cysteine-type peptidase 
activity 
cathepsin C, homolog Y 
9 PF14_0761 1.5912 long-chain-fatty-acid-CoA 
ligase activity 
acyl-CoA synthetase Y 
10 PF11_0212 1.6314 nucleotidyltransferase 
activity, RNA binding, 
molecular_function 
tRNA nucleotidyltransferase, 
putative 
Y 
11 PF13_0265 1.6363 N/A conserved, unknown function Y 
12 PF10_0208 1.6593 molecular_function endomembrane protein 70, 
putative 
Y 
13 PFI0700c 1.6621 N/A met-10+ like protein, putative Y 
14 PFE1150w 0.7 ATP binding, multidrug 
efflux pump activity, ATPase 
activity, coupled to 
transmembrane movement of 
substances 
multidrug resistance protein - 
15 PFA0375c 0.7945 hedgehog receptor activity lipid/sterol:H+ symporter - 
16 PFF1430c 1.1409 amino acid transmembrane 
transporter activity 
amino acid transporter, 
putative 
- 
17 PF11_0384 1.1989 molecular_function cleft lip and palate associated 
transmembrane protein-related 
- 
18 PFD0415c 1.2852 N/A conserved, unknown function - 
19 PF14_0477 1.2992 signal sequence binding, 
GTP binding, nucleoside-
triphosphatase activity, 7S 
RNA binding 
signal recognition particle 
SRP54, putative 
- 
20 PFI1085w 1.3033 N/A ubiquitin-like protein, putative - 
21 PF14_0528 1.3126 molecular_function hemolysin, putative - 
 
 
 
 
 
 
 
Table 4. Expression profile similarity to PfPV1. Search on PlasmoDB for 100 genes 
that have a (glass slide) expression profile similar to that of PfPV1, distance method by 
Euclidean distance in 3D7 parasite, no time shift allowed. A secondary search found 13 
genes that contain a predicted signal peptide. The list on this table was extracted for top 
21 genes, first selected on signal peptide presence (genes from no. 1 to no. 13); followed 
by profile distance (genes from no. 14 to no. 21, in italic). N/A: not annotated yet; Y in 
SignalP peptide column: contains signal peptide. Data were extracted from PlasmoDB 
(Aurrecoechea et al., 2009).  
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Summary 
 
Malaria is one of the most lethal infectious diseases worldwide. Understanding the 
biology of the causative agent Plasmodium will lead to better control of the disease. 
The biogenesis and maintenance of the parasitophorous vacuole (PV) within the 
infected erythrocyte is an essential factor for parasite survival. The PV has been 
postulated to be involved in various pivotal functions, however little is known about 
the PV contents and their respective functions. Our group had previously provided the 
first PV’s proteome research and have continuously exposed more members of this 
important compartment. The protein PfPV1 was a newly discovered PV localisation 
protein, encoded by the PF11_0302 gene. In order to address the function of this 
protein a gene knock-out strategy was applied. A search for the interacting proteins of 
PfPV1 was also carried out using the GST pull-down assay. 
 
The first attempt to knock out the encoding gene was the double-crossover strategy in 
the presence of a negative selection. The knocked-out parasite was unable to obtain. 
However, the integration into the PfPV1 locus did occur, evidenced by the presence of 
both endogenous and knock-out band in the specific southern blot hybridisation. The 
PfPV1 gene was therefore assumed to be essential for in vitro growth, thus the 
targeting into the endogenous locus was accompanied by a duplication event for 
maintaining expression of the gene.  
 
The assumption was further validated by the second knock-out strategy, using the 
complementing experiment. The result had been expected to be able to disrupt the 
endogenous gene locus through the knock-out vector while concomitantly expressing 
a copy of PfPV1 under the control of a foreign promoter from an episomal plasmid, 
which should not recombine with the endogenous gene locus. However, the gene was 
still resistant to be disrupted. Various clones were isolated from the double transfected 
parasites. One of the clones has lost the episomal copy of the PfPV1 gene and showed 
the same southern blot result as the single transfected parasite, indicating that the 
parasite needs to maintain the expression of the endogenous gene. Other clones, if 
keeping the episomal copy of the PfPV1, did not show the specific integration. The 
result strongly suggests that the PfPV1 expression needs to be controlled by its 
endogenous promoter to be fully active.  
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The data has also proved for the first time that in some cases of the negative selection 
strategy, upon the integration, the Plasmodium parasite might rearrange the thymidine 
kinase encoding sequence in order to inactivate its activity, therefore prevent the 
lethal effect from converting ganciclovir to toxic metabolite.  
 
In the GST pull-down assay, no interacting protein was obtained. However, the 
experiment was carried out with the cell extract from trophozoite-stage parasites, thus 
might not detect interactions at other stages. 
 
In conclusion, the data suggest that PfPV1 is a conserved, unique protein with 
unknown but essential function during the intraerythrocytic cycle.  
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Zusammenfassung 
 
 
Die Malaria ist noch immer eine der verheerendsten Infektionskrankheiten weltweit. 
Das Verständnis der Biologie des ihr zugrunde liegenden Pathogens, Plasmodium 
falciparum ist notwendig, um erfolgreich gegen diese Krankheit vorzugehen. Dabei 
ist die Genese und Aufrechterhaltung der parasitophoren Vakuole (PV) innerhalb des 
Erythrozyten ein essentieller Faktor für das Überleben des Parasiten. Obwohl diese 
grundlegende Bedeutung für den Parasiten bekannt ist, bleibt die genaue 
Zusammensetzung und die Funktion vieler Bestandteile der PV weiter ungeklärt. 
Unsere Gruppe hat dabei das erste Proteom dieses Kompartiments veröffentlicht und 
in der Vergangenheit  weitere Komponenten desselben identifiziert. PfPV1 ist eines 
dieser neu entdeckten Proteine. Um Informationen bezüglich der Funktion dieses 
Proteins gewinnen zu können, wurde in der vorliegenden Arbeit eine Knock-out 
Strategie gewählt. Zudem wurde versucht, Interaktionspartner von PfPV1 mit Hilfe 
von GST Pull-Down Assays zu identifizieren. 
 
Beim ersten Versuch des Knock-outs wurde eine Double-Crossover Strategie mit 
negativer Selektion verfolgt, wobei sich der erhaltene Knock-out Parasit nicht weiter 
kultivieren ließ. Die Integration in den PfPV1- Lokus war jedoch erfolgreich und so 
wurde bei der spezifischen Southern-Blot Hybridisierung sowohl eine endogene als 
auch eine Knock- Out Bande detektiert. Die Schlussfolgerung aus diesen Ergebnissen 
ist, dass PfPV1 für das Überleben des Parasiten in-vitro essentiell ist, und dass im 
Zuge der Integration in den endogenen Lokus eine Duplikation stattgefunden haben 
muss, welche die weitere Expression des Gens sichergestellt hat. 
 
Die obige Annahme wurde durch die Ergebnisse der zweiten Knock-Out Strategie 
weiter bestätigt. Hierbei wurde versucht, das endogene Gen mit Hilfe eines Knock- 
Out Vektors zu zerstören, während gleichzeitig PfPV1 unter der Kontrolle eines 
fremden Promotors von einem episomalen Plasmid exprimiert wird, welches nicht 
fähig ist mit dem endogenen Lokus zu rekombinieren. Jedoch ließ sich auch mit Hilfe 
dieses Ansatzes das PfPV1-Gen nicht zerstören. Die Analyse verschiedener Klone der 
doppelt transfizierten Parasiten zeigte folgende Ergebnisse. Bei einem der Klone war 
festzustellen, dass die episomale Kopie von PfPV1 verloren gegangen war. Dieser 
Klon zeigte zu dem dasselbe Muster im Southern- Blot wie die einzel transfizierten 
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Parasiten. Dies geht konform mit der oben genannten Annahme, dass der Parasit zum 
Überleben auf die Expression des endogenen Gens angewiesen ist. Weitere Klone 
zeigten bei der Analyse, sofern sie die episomale Kopie behalten hatten, keine 
erfolgreiche Integration. Diese Ergebnisse weisen darauf hin, dass die erfolgreiche 
Expression von PfPV1 die Kontrolle des endogenen Promoters benötigt. 
Die während dieser Arbeit generierten Daten zeigen zum ersten Mal, dass die negative 
Selektionsstrategie bei Integration dazu führen kann, dass bei Plasmodium falciparum 
die Thymidin-Kinase kodierende Sequenz dahingehend modifiziert wird, dass sie ihre 
Aktivität einbüßt und Ganciclovir nicht mehr in seine toxische Form überführt. 
 
Bezüglich des GST pull down Assays gelang es nicht interagierende Proteine zu 
identifizieren. Möglicherweise finden Interaktionen mit PfPV1 jedoch in 
Entwicklungsstadien des Parasiten statt, die in dieser Arbeit nicht berücksichtigt 
wurden. 
 
Zusammengefasst lassen sich die Ergebnisse dieser Arbeit so interpretieren, dass 
PfPV1 ein einzigartiges, konserviertes Protein mit essentieller, aber noch unbekannter 
Funktion darstellt. 
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